Various	O
modes	O
of	O
basic	B-protein
helix-loop-helix	I-protein
protein	I-protein
-mediated	O
regulation	O
of	O
murine	O
leukemia	O
virus	O
transcription	O
in	O
lymphoid	B-cell_line
cell	I-cell_line
lines	I-cell_line
.	O

The	O
transcriptionally	B-DNA
regulatory	I-DNA
regions	I-DNA
of	O
the	O
lymphomagenic	O
Akv	O
and	O
SL3-3	O
murine	O
leukemia	O
retroviruses	O
(	O
MLVs	O
)	O
contain	O
two	O
types	O
of	O
E-box	B-DNA
consensus	I-DNA
motifs	I-DNA
,	O
CAGATG	O
.	O

One	O
type	O
,	O
EA/S	B-DNA
,	O
is	O
located	O
in	O
the	O
upstream	B-DNA
promoter	I-DNA
region	I-DNA
,	O
and	O
the	O
other	O
,	O
E	B-DNA
(	I-DNA
gre	I-DNA
)	I-DNA
,	O
is	O
located	O
in	O
a	O
tandem	B-DNA
repeat	I-DNA
with	O
enhancer	O
properties	O
.	O

We	O
have	O
examined	O
the	O
requirements	O
of	O
the	O
individual	O
E-boxes	B-DNA
in	O
MLV	O
transcriptional	O
regulation	O
.	O

In	O
lymphoid	B-cell_line
cell	I-cell_line
lines	I-cell_line
only	O
,	O
the	O
E	B-protein
(	I-protein
gre	I-protein
)	I-protein
-binding	I-protein
protein	I-protein
complexes	I-protein
included	O
ALF1	B-protein
or	O
HEB	B-protein
and	O
E2A	B-protein
basic	I-protein
helix-loop-helix	I-protein
proteins	I-protein
.	O

Ectopic	O
ALF1	B-protein
and	O
E2A	B-protein
proteins	I-protein
required	O
intact	O
E	B-DNA
(	I-DNA
gre	I-DNA
)	I-DNA
motifs	I-DNA
for	O
mediating	O
transcriptional	O
activation	O
.	O

ALF1	B-protein
transactivated	O
transcription	O
of	O
Akv	O
MLV	O
through	O
the	O
two	O
E	B-DNA
(	I-DNA
gre	I-DNA
)	I-DNA
motifs	I-DNA
equally	O
,	O
whereas	O
E2A	B-protein
protein	I-protein
required	O
the	O
promoter-proximal	O
E	B-DNA
(	I-DNA
gre	I-DNA
)	I-DNA
motif	O
.	O

In	O
T-	B-cell_line
and	I-cell_line
B-cell	I-cell_line
lines	I-cell_line
,	O
the	O
E	B-DNA
(	I-DNA
gre	I-DNA
)	I-DNA
motifs	I-DNA
were	O
of	O
major	O
importance	O
for	O
Akv	O
MLV	O
transcriptional	O
activity	O
,	O
while	O
the	O
EA/S	B-DNA
motif	I-DNA
had	O
some	O
effect	O
.	O

In	O
contrast	O
,	O
neither	O
E	B-DNA
(	I-DNA
gre	I-DNA
)	I-DNA
nor	O
EA/S	B-DNA
motifs	I-DNA
contributed	O
pronouncedly	O
to	O
Akv	O
MLV	O
transcription	O
in	O
NIH	B-cell_line
3T3	I-cell_line
cells	I-cell_line
lacking	O
DNA-binding	O
ALF1	B-protein
or	O
HEB	B-protein
and	O
E2A	B-protein
proteins	I-protein
.	O

The	O
Id1	O
protein	O
was	O
found	O
to	O
repress	O
ALF1	B-protein
activity	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

Moreover	O
,	O
ectopic	B-protein
Id1	I-protein
repressed	O
E	B-DNA
(	I-DNA
gre	I-DNA
)	I-DNA
-directed	O
but	O
not	O
EA/S	B-DNA
-directed	O
MLV	O
transcription	O
in	O
lymphoid	B-cell_line
cell	I-cell_line
lines	I-cell_line
.	O

In	O
conclusion	O
,	O
E	B-DNA
(	I-DNA
gre	I-DNA
)	I-DNA
motifs	O
and	O
interacting	O
basic	B-protein
helix-loop-helix	I-protein
proteins	I-protein
are	O
important	O
determinants	O
for	O
MLV	O
transcriptional	O
activity	O
in	O
lymphocytic	B-cell_line
cell	I-cell_line
lines	I-cell_line
.	O

JOURNAL	NULL
OF	NULL
ViRoLOGY	NULL
,	NULL
Sept.	NULL
1996	NULL
,	NULL
p.	NULL
5893-5901	NULL
0022-538X	NULL
,	NULL
/96/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1996	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

70	NULL
,	NULL
No	NULL
.	NULL

9	NULL
Various	NULL
Modes	NULL
of	NULL
Basic	NULL
Helix-Loop-Helix	NULL
Protein-Mediated	NULL
Regulation	NULL
of	NULL
Murine	NULL
Leukemia	NULL
Virus	NULL
Transcription	NULL
in	NULL
Lymphoid	NULL
Cell	NULL
Lines	NULL
ANDERS	NULL
LADE	NULL
NIELSEN	NULL
,	NULL
'	NULL
f	NULL
PEDER	NULL
LISBY	NULL
NRBY	NULL
,	NULL
'	NULL
FINN	NULL
SKOU	NULL
PEDERSEN	NULL
,	NULL
``	NULL
AND	NULL
POUL	NULL
JORGENSEN'*	NULL
Department	NULL
of	NULL
Molecular	NULL
and	NULL
Structural	NULL
Biology	NULL
and	NULL
Department	NULL
of	NULL
Medical	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
``	NULL
University	NULL
of	NULL
Aarhus	NULL
,	NULL
DK-8000	NULL
Aarhus	NULL
C	NULL
,	NULL
Denmark	NULL
Received	NULL
30	NULL
October	NULL
1995/Accepted	NULL
10	NULL
May	NULL
1996	NULL
The	NULL
transcriptionally	NULL
regulatory	NULL
regions	NULL
of	NULL
the	NULL
Iymphomagenic	NULL
Akyv	NULL
and	NULL
SL3-3	NULL
murine	NULL
leukemia	NULL
retroviruses	NULL
(	NULL
MLVs	NULL
)	NULL
contain	NULL
two	NULL
types	NULL
of	NULL
E-box	NULL
consensus	NULL
motifs	NULL
,	NULL
CAGATG	NULL
.	NULL

One	NULL
type	NULL
,	NULL
Ey	NULL
,	NULL
is	NULL
located	NULL
in	NULL
the	NULL
upstream	NULL
promoter	NULL
region	NULL
,	NULL
and	NULL
the	NULL
other	NULL
,	NULL
E	NULL
,	NULL
,	NULL
,	NULL
.	NULL

,	NULL
,	NULL
is	NULL
located	NULL
in	NULL
a	NULL
tandem	NULL
repeat	NULL
with	NULL
enhancer	NULL
properties	NULL
.	NULL

We	NULL
have	NULL
examined	NULL
the	NULL
requirements	NULL
of	NULL
the	NULL
individual	NULL
E-boxes	NULL
in	NULL
MLV	NULL
transcriptional	NULL
regulation	NULL
.	NULL

In	NULL
lymphoid	NULL
cell	NULL
lines	NULL
only	NULL
,	NULL
the	NULL
E	NULL
,	NULL
,	NULL
,	NULL
-binding	NULL
protein	NULL
complexes	NULL
included	NULL
ALF1	NULL
or	NULL
HEB	NULL
and	NULL
E2A	NULL
basic	NULL
helix-loop-helix	NULL
proteins	NULL
.	NULL

Ectopic	NULL
ALF1	NULL
and	NULL
E2A	NULL
proteins	NULL
required	NULL
intact	NULL
E.	NULL
,	NULL
,	NULL
motifs	NULL
for	NULL
mediating	NULL
transcriptional	NULL
activation	NULL
.	NULL

ALF1	NULL
transactivated	NULL
transcription	NULL
of	NULL
Aky	NULL
MLV	NULL
through	NULL
the	NULL
two	NULL
E	NULL
,	NULL
,	NULL
,	NULL
motifs	NULL
equally	NULL
,	NULL
whereas	NULL
E2A	NULL
protein	NULL
required	NULL
the	NULL
promoter-proximal	NULL
E	NULL
,	NULL
,	NULL
,	NULL
motif	NULL
.	NULL

In	NULL
T-	NULL
and	NULL
B-cell	NULL
lines	NULL
,	NULL
the	NULL
E	NULL
,	NULL
,	NULL
,	NULL
motifs	NULL
were	NULL
of	NULL
major	NULL
importance	NULL
for	NULL
Aky	NULL
MLV	NULL
transcriptional	NULL
activity	NULL
,	NULL
while	NULL
the	NULL
E	NULL
,	NULL
,	NULL
;	NULL
motif	NULL
had	NULL
some	NULL
effect	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
neither	NULL
E	NULL
,	NULL
,	NULL
,	NULL
nor	NULL
E	NULL
,	NULL
,	NULL
;	NULL
motifs	NULL
contributed	NULL
pronouncedly	NULL
to	NULL
Aky	NULL
MLV	NULL
transcription	NULL
in	NULL
NIH	NULL
3T3	NULL
cells	NULL
lacking	NULL
DNA-binding	NULL
ALF1	NULL
or	NULL
HEB	NULL
and	NULL
E2A	NULL
proteins	NULL
.	NULL

The	NULL
Id1	NULL
protein	NULL
was	NULL
found	NULL
to	NULL
repress	NULL
ALFA	NULL
activity	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
.	NULL

Moreover	NULL
,	NULL
ectopic	NULL
Id1	NULL
repressed	NULL
E	NULL
,	NULL
.	NULL

,	NULL
-directed	NULL
but	NULL
not	NULL
Ep	NULL
,	NULL
g-directed	NULL
MLV	NULL
transcription	NULL
in	NULL
lymphoid	NULL
cell	NULL
lines	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
E	NULL
,	NULL
,	NULL
,	NULL
motifs	NULL
and	NULL
interacting	NULL
basic	NULL
helix-loop-helix	NULL
proteins	NULL
are	NULL
important	NULL
determinants	NULL
for	NULL
MLV	NULL
transcriptional	NULL
activity	NULL
in	NULL
lymphocytic	NULL
cell	NULL
lines	NULL
.	NULL

Endogenous	NULL
retrovirus	NULL
expression	NULL
may	NULL
result	NULL
in	NULL
induction	NULL
of	NULL
neoplastic	NULL
diseases	NULL
in	NULL
mice	NULL
(	NULL
44	NULL
)	NULL
.	NULL

Within	NULL
the	NULL
first	NULL
year	NULL
of	NULL
life	NULL
,	NULL
mice	NULL
of	NULL
the	NULL
inbred	NULL
AKR	NULL
strain	NULL
develop	NULL
thymic	NULL
lymphomas	NULL
.	NULL

SL3-3	NULL
murine	NULL
leukemia	NULL
virus	NULL
(	NULL
MLV	NULL
)	NULL
,	NULL
isolated	NULL
from	NULL
a	NULL
lymphoid	NULL
AKR	NULL
tumor	NULL
cell	NULL
line	NULL
,	NULL
induces	NULL
exclusively	NULL
thymic	NULL
lymphomas	NULL
when	NULL
injected	NULL
in	NULL
newborn	NULL
NMRI	NULL
mice	NULL
,	NULL
whereas	NULL
the	NULL
AKR	NULL
endogenous	NULL
MLV	NULL
,	NULL
Akyv	NULL
,	NULL
induces	NULL
a	NULL
broader	NULL
spectrum	NULL
of	NULL
dis-eases	NULL
,	NULL
including	NULL
B	NULL
and	NULL
T	NULL
lymphomas	NULL
,	NULL
myelogenous	NULL
leukemia	NULL
,	NULL
and	NULL
nondifferentiated	NULL
leukemia	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Lymphomagenesis	NULL
is	NULL
linked	NULL
to	NULL
the	NULL
activity	NULL
and	NULL
cell	NULL
type	NULL
specificity	NULL
of	NULL
the	NULL
MLV	NULL
enhancer	NULL
in	NULL
the	NULL
U3	NULL
part	NULL
of	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
;	NULL
e.g	NULL
.	NULL

,	NULL
the	NULL
enhancer	NULL
of	NULL
the	NULL
T-lymphomagenic	NULL
SL3-3	NULL
MLV	NULL
directs	NULL
greater	NULL
transcriptional	NULL
activity	NULL
in	NULL
T-cell	NULL
lines	NULL
than	NULL
does	NULL
the	NULL
corresponding	NULL
enhancer	NULL
region	NULL
of	NULL
Aky	NULL
MLV	NULL
(	NULL
6	NULL
,	NULL
7	NULL
,	NULL
23	NULL
)	NULL
.	NULL

The	NULL
MLV	NULL
U3	NULL
regions	NULL
represent	NULL
an	NULL
amalgamation	NULL
of	NULL
several	NULL
cis	NULL
transcriptional	NULL
regulatory	NULL
sequences	NULL
.	NULL

Recently	NULL
,	NULL
basic	NULL
helix-loop-helix	NULL
(	NULL
bHLH	NULL
)	NULL
transcription	NULL
factors	NULL
and	NULL
their	NULL
cognate	NULL
DNA	NULL
recognition	NULL
sequence	NULL
,	NULL
CANNTG	NULL
(	NULL
E-box	NULL
)	NULL
,	NULL
have	NULL
been	NULL
characterized	NULL
as	NULL
putative	NULL
mediators	NULL
of	NULL
MLV	NULL
transcription	NULL
regulation	NULL
(	NULL
9	NULL
,	NULL
21	NULL
,	NULL
28	NULL
,	NULL
31	NULL
,	NULL
32	NULL
)	NULL
.	NULL

The	NULL
bHLH	NULL
transcription	NULL
factors	NULL
are	NULL
involved	NULL
in	NULL
cell	NULL
growth	NULL
control	NULL
and	NULL
transformation	NULL
,	NULL
sex	NULL
deter-mination	NULL
,	NULL
pancreas	NULL
gene	NULL
expression	NULL
,	NULL
neurogenesis	NULL
,	NULL
muscle	NULL
dif-ferentiation	NULL
,	NULL
and	NULL
hematopoietic	NULL
gene	NULL
expression	NULL
and	NULL
differentiation	NULL
(	NULL
reviewed	NULL
in	NULL
reference	NULL
26	NULL
)	NULL
.	NULL

The	NULL
cDNA	NULL
cloning	NULL
of	NULL
the	NULL
human	NULL
bHLH	NULL
protein	NULL
SEF-2	NULL
or	NULL
E2-2	NULL
was	NULL
based	NULL
on	NULL
its	NULL
in	NULL
vitro	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Molecular	NULL
and	NULL
Structural	NULL
Biology	NULL
,	NULL
University	NULL
of	NULL
Aarhus	NULL
,	NULL
C.	NULL
F.	NULL
Mgllers	NULL
Allé	NULL
130	NULL
,	NULL
DK-8000	NULL
Aarhus	NULL
C	NULL
,	NULL
Denmark	NULL
.	NULL

Phone	NULL
:	NULL
45-8942	NULL
2615	NULL
.	NULL

Fax	NULL
:	NULL
45-8619	NULL
6500	NULL
.	NULL

Electronic	NULL
mail	NULL
address	NULL
:	NULL
poul	NULL
@	NULL
mbio.aau.dk	NULL
.	NULL

{	NULL
Present	NULL
address	NULL
:	NULL
Institut	NULL
de	NULL
Genetique	NULL
et	NULL
de	NULL
Biologie	NULL
Moleculaire	NULL
et	NULL
Cellulaire	NULL
,	NULL
Centre	NULL
National	NULL
de	NULL
la	NULL
Recherche	NULL
Scientifique	NULL
,	NULL
Institut	NULL
National	NULL
de	NULL
la	NULL
Recherche	NULL
Scientifique	NULL
,	NULL
ULP	NULL
,	NULL
College	NULL
de	NULL
France	NULL
,	NULL
67404	NULL
Illkirch	NULL
Cedex	NULL
,	NULL
C.U	NULL
.	NULL

de	NULL
Strasbourg	NULL
,	NULL
France	NULL
.	NULL

5893	NULL
capacity	NULL
to	NULL
bind	NULL
E-boxes	NULL
in	NULL
the	NULL
SL3-3	NULL
MLV	NULL
enhancer	NULL
(	NULL
9	NULL
)	NULL
,	NULL
whereas	NULL
murine	NULL
ALF1	NULL
and	NULL
ALF2	NULL
or	NULL
E2A	NULL
were	NULL
cDNA	NULL
cloned	NULL
by	NULL
affinity	NULL
to	NULL
the	NULL
identical	NULL
Akvy	NULL
MLV	NULL
E-boxes	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Human	NULL
and	NULL
rat	NULL
analogs	NULL
to	NULL
ALF1	NULL
are	NULL
termed	NULL
HEB/HTF4	NULL
and	NULL
REB	NULL
,	NULL
respectively	NULL
(	NULL
17	NULL
,	NULL
20	NULL
,	NULL
46	NULL
)	NULL
.	NULL

HEB	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
have	NULL
affinity	NULL
for	NULL
E-boxes	NULL
in	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
,	NULL
immunoglobulin	NULL
enhancers	NULL
,	NULL
and	NULL
CD4	NULL
enhancer	NULL
(	NULL
10	NULL
,	NULL
17	NULL
,	NULL
38	NULL
,	NULL
47	NULL
)	NULL
.	NULL

In	NULL
transient-transfection	NULL
assays	NULL
,	NULL
ALFI1	NULL
can	NULL
frens	NULL
activate	NULL
transcription	NULL
from	NULL
Akv	NULL
,	NULL
SL3-3	NULL
,	NULL
and	NULL
the	NULL
thymotropic	NULL
Moloney	NULL
MLV	NULL
U3	NULL
regions	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
erythrotropic	NULL
Friend	NULL
spleen	NULL
focus-forming	NULL
virus	NULL
,	NULL
but	NULL
not	NULL
from	NULL
the	NULL
erythrotropic	NULL
Friend	NULL
MLV	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
bHLH	NULL
transcription	NULL
factor	NULL
E47	NULL
can	NULL
transactivate	NULL
transcription	NULL
of	NULL
recombinant	NULL
MLVs	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Class	NULL
A	NULL
bHLH	NULL
proteins	NULL
include	NULL
E12	NULL
,	NULL
E47	NULL
,	NULL
and	NULL
E2-5	NULL
,	NULL
all	NULL
encoded	NULL
by	NULL
the	NULL
E2A	NULL
gene	NULL
(	NULL
13	NULL
,	NULL
27	NULL
)	NULL
;	NULL
SEF-2	NULL
or	NULL
E2-2	NULL
(	NULL
9	NULL
,	NULL
13	NULL
)	NULL
;	NULL
and	NULL
ALF1	NULL
,	NULL
HEB	NULL
,	NULL
or	NULL
HTF4	NULL
(	NULL
17	NULL
,	NULL
31	NULL
,	NULL
46	NULL
)	NULL
.	NULL

Class	NULL
A	NULL
bHLH	NULL
proteins	NULL
regulate	NULL
tissue-specific	NULL
gene	NULL
expression	NULL
and	NULL
differentiation	NULL
by	NULL
binding	NULL
to	NULL
DNA	NULL
as	NULL
either	NULL
homodimers	NULL
or	NULL
heterodimers	NULL
with	NULL
other	NULL
class	NULL
A	NULL
bHLH	NULL
or	NULL
with	NULL
class	NULL
B	NULL
bHLH	NULL
proteins	NULL
,	NULL
such	NULL
as	NULL
TAL1	NULL
or	NULL
SCL	NULL
and	NULL
myogenic	NULL
factors	NULL
(	NULL
15	NULL
,	NULL
28	NULL
)	NULL
.	NULL

Class	NULL
B	NULL
bHLH	NULL
proteins	NULL
do	NULL
not	NULL
bind	NULL
to	NULL
DNA	NULL
as	NULL
homodimers	NULL
but	NULL
require	NULL
heterodimer	NULL
formation	NULL
with	NULL
class	NULL
A	NULL
bHLH	NULL
proteins	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Class	NULL
A	NULL
bHLH	NULL
proteins	NULL
can	NULL
form	NULL
heterodimers	NULL
with	NULL
helix-loop-helix	NULL
proteins	NULL
lacking	NULL
the	NULL
basic	NULL
domain	NULL
required	NULL
for	NULL
DNA	NULL
binding	NULL
,	NULL
the	NULL
Id	NULL
proteins	NULL
(	NULL
4	NULL
,	NULL
8	NULL
,	NULL
37	NULL
,	NULL
43	NULL
)	NULL
.	NULL

Id	NULL
proteins	NULL
are	NULL
dominant	NULL
negative	NULL
for	NULL
class	NULL
A	NULL
bHLH	NULL
protein-mediated	NULL
transcriptional	NULL
activation	NULL
,	NULL
and	NULL
Id	NULL
mRNA	NULL
expression	NULL
is	NULL
inversely	NULL
correlated	NULL
with	NULL
class	NULL
A	NULL
bHLH	NULL
protein	NULL
activity	NULL
(	NULL
4	NULL
,	NULL
36	NULL
,	NULL
45	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
a	NULL
family	NULL
of	NULL
proteins	NULL
coding	NULL
for	NULL
zinc	NULL
finger	NULL
domain	NULL
proteins	NULL
have	NULL
also	NULL
been	NULL
identified	NULL
as	NULL
repressors	NULL
of	NULL
bHLH	NULL
activity	NULL
,	NULL
e.g	NULL
.	NULL

,	NULL
ZEB	NULL
and	NULL
8EF1	NULL
(	NULL
11	NULL
,	NULL
39	NULL
)	NULL
.	NULL

Instead	NULL
of	NULL
mediating	NULL
repression	NULL
through	NULL
protein-pro-tein	NULL
interactions	NULL
,	NULL
this	NULL
protein	NULL
family	NULL
represses	NULL
class	NULL
A	NULL
bHLH	NULL
protein	NULL
activity	NULL
through	NULL
competition	NULL
for	NULL
the	NULL
E-box	NULL
binding	NULL
site	NULL
(	NULL
11	NULL
)	NULL
.	NULL

5894	NULL
NIELSEN	NULL
ET	NULL
AL	NULL
.	NULL

Class	NULL
A	NULL
bHLH	NULL
proteins	NULL
have	NULL
been	NULL
intensively	NULL
studied	NULL
with	NULL
respect	NULL
to	NULL
transcriptional	NULL
regulation	NULL
in	NULL
hematopoietic	NULL
cells	NULL
(	NULL
13	NULL
,	NULL
18	NULL
,	NULL
29	NULL
,	NULL
38	NULL
)	NULL
.	NULL

Ectopic	NULL
expression	NULL
of	NULL
the	NULL
class	NULL
A	NULL
bHLH	NULL
dominant-negative	NULL
Id1	NULL
protein	NULL
in	NULL
transgenic	NULL
mice	NULL
resulted	NULL
in	NULL
a	NULL
decrease	NULL
in	NULL
B-cell	NULL
formation	NULL
(	NULL
41	NULL
)	NULL
.	NULL

Targeted	NULL
gene	NULL
disruption	NULL
in	NULL
mice	NULL
has	NULL
recently	NULL
shown	NULL
the	NULL
importance	NULL
of	NULL
class	NULL
A	NULL
bHLH	NULL
proteins	NULL
in	NULL
hematopoietic	NULL
development	NULL
(	NULL
2	NULL
,	NULL
48	NULL
)	NULL
.	NULL

Mice	NULL
with	NULL
the	NULL
E2A	NULL
gene	NULL
deleted	NULL
contain	NULL
no	NULL
B	NULL
cells	NULL
,	NULL
whereas	NULL
other	NULL
lineages	NULL
,	NULL
including	NULL
T-cell	NULL
,	NULL
granulocyte	NULL
,	NULL
macrophage	NULL
,	NULL
and	NULL
erythroid	NULL
lineages	NULL
,	NULL
are	NULL
relatively	NULL
intact	NULL
.	NULL

This	NULL
may	NULL
suggest	NULL
an	NULL
incomplete	NULL
functional	NULL
redundancy	NULL
in	NULL
gene	NULL
regulation	NULL
among	NULL
the	NULL
very	NULL
homologous	NULL
class	NULL
A	NULL
bHLH	NULL
proteins	NULL
(	NULL
2	NULL
,	NULL
48	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
found	NULL
that	NULL
MLV	NULL
E-box-binding	NULL
protein	NULL
complexes	NULL
in	NULL
lymphoid	NULL
cell	NULL
lines	NULL
included	NULL
ALF1	NULL
or	NULL
HEB	NULL
and	NULL
ALF2	NULL
or	NULL
E2A	NULL
bHLH	NULL
subunits	NULL
and	NULL
that	NULL
ALF1	NULL
and	NULL
E2A	NULL
proteins	NULL
had	NULL
stringent	NULL
E-box	NULL
requirements	NULL
for	NULL
transcriptional	NULL
transactivation	NULL
.	NULL

Intact	NULL
E-box	NULL
motifs	NULL
were	NULL
found	NULL
to	NULL
have	NULL
major	NULL
importance	NULL
for	NULL
active	NULL
MLV	NULL
transcription	NULL
in	NULL
lymphoid	NULL
cell	NULL
lines	NULL
,	NULL
and	NULL
ectopic	NULL
Id1	NULL
reduced	NULL
the	NULL
MLV	NULL
transcriptional	NULL
rate	NULL
.	NULL

Our	NULL
analysis	NULL
showed	NULL
that	NULL
MLV	NULL
enhancer	NULL
E-boxes	NULL
and	NULL
corresponding	NULL
bHLH	NULL
transcription	NULL
factors	NULL
are	NULL
important	NULL
determinants	NULL
for	NULL
MLV	NULL
transcription	NULL
in	NULL
Id-negative	NULL
cells	NULL
such	NULL
as	NULL
lymphocytes	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
lines	NULL
.	NULL

NIH	NULL
3T3	NULL
fibroblasts	NULL
,	NULL
HeLa	NULL
epitheloid	NULL
carcinoma	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
Mpc11	NULL
immunoglobulin-secreting	NULL
B-cell	NULL
line	NULL
were	NULL
maintained	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium-10	NULL
%	NULL
newborn	NULL
calf	NULL
serum-2	NULL
%	NULL
penicillin-streptomycin	NULL
.	NULL

1691-6	NULL
and	NULL
WEHI7.1	NULL
T-cell	NULL
lines	NULL
,	NULL
the	NULL
J558L	NULL
immunoglobulin-secreting	NULL
B-cell	NULL
line	NULL
,	NULL
and	NULL
K562	NULL
erythroleukemia	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
medium-10	NULL
%	NULL
newborn	NULL
calf	NULL
serum-2	NULL
%	NULL
penicillin-streptomycin	NULL
.	NULL

All	NULL
cells	NULL
were	NULL
grown	NULL
with	NULL
5.6	NULL
%	NULL
CO	NULL
;	NULL
,	NULL
at	NULL
37°C	NULL
.	NULL

Chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
vector	NULL
constructions	NULL
.	NULL

The	NULL
pAKV6	NULL
CAT	NULL
,	NULL
pSL3-3CAT	NULL
,	NULL
and	NULL
p1-99CAT	NULL
constructs	NULL
were	NULL
described	NULL
previously	NULL
(	NULL
34	NULL
)	NULL
.	NULL

To	NULL
generate	NULL
pE	NULL
(	NULL
c	NULL
)	NULL
CAT	NULL
,	NULL
the	NULL
mutational	NULL
primer	NULL
5231	NULL
(	NULL
CCCCGGTCATCTTGGGA	NULL
ACCTTG	NULL
;	NULL
E-box	NULL
in	NULL
italics	NULL
and	NULL
mutation	NULL
underlined	NULL
)	NULL
and	NULL
an	NULL
oligonucleotide	NULL
primer	NULL
in	NULL
excess	NULL
corresponding	NULL
to	NULL
the	NULL
R	NULL
sequence	NULL
at	NULL
the	NULL
KpnI	NULL
site	NULL
were	NULL
used	NULL
in	NULL
an	NULL
asymmetric	NULL
PCR	NULL
with	NULL
p1-99CAT	NULL
as	NULL
a	NULL
template	NULL
in	NULL
a	NULL
Hybaid	NULL
OmniGene	NULL
temperature	NULL
cycler	NULL
.	NULL

The	NULL
single-stranded	NULL
PCR	NULL
product	NULL
was	NULL
purified	NULL
and	NULL
used	NULL
as	NULL
a	NULL
primer	NULL
in	NULL
an	NULL
additional	NULL
PCR	NULL
with	NULL
a	NULL
primer	NULL
corresponding	NULL
to	NULL
sequences	NULL
including	NULL
Pstl	NULL
in	NULL
the	NULL
upstream	NULL
U3	NULL
region	NULL
.	NULL

The	NULL
fragment	NULL
was	NULL
digested	NULL
with	NULL
Psfl	NULL
and	NULL
KpnI	NULL
and	NULL
cloned	NULL
in	NULL
the	NULL
corresponding	NULL
sites	NULL
of	NULL
pAKV6CAT	NULL
.	NULL

To	NULL
generate	NULL
pF	NULL
(	NULL
ab	NULL
)	NULL
CAT	NULL
,	NULL
a	NULL
139-nucleotide	NULL
oligonucleotide	NULL
with	NULL
mutations	NULL
in	NULL
both	NULL
Akvy	NULL
MLV	NULL
enhancer	NULL
E-boxes	NULL
and	NULL
a	NULL
tag	NULL
primer	NULL
nonhomologous	NULL
to	NULL
Aky	NULL
MLV	NULL
sequences	NULL
for	NULL
recovery	NULL
of	NULL
the	NULL
full-length	NULL
PCR	NULL
products	NULL
(	NULL
see	NULL
reference	NULL
32	NULL
)	NULL
were	NULL
used	NULL
in	NULL
a	NULL
standard	NULL
PCR	NULL
with	NULL
the	NULL
KpnI	NULL
site	NULL
corresponding	NULL
primer	NULL
.	NULL

The	NULL
PCR	NULL
product	NULL
was	NULL
digested	NULL
with	NULL
KprI	NULL
and	NULL
partially	NULL
digested	NULL
with	NULL
Apel	NULL
,	NULL
and	NULL
the	NULL
longest	NULL
Apal-KpnI	NULL
fragment	NULL
(	NULL
343	NULL
bp	NULL
)	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
corresponding	NULL
sites	NULL
of	NULL
p1-99CAT	NULL
.	NULL

pE	NULL
(	NULL
abe	NULL
)	NULL
was	NULL
generated	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Vector	NULL
constructs	NULL
with	NULL
all	NULL
combinations	NULL
of	NULL
wild-type	NULL
and	NULL
mutational	NULL
E-boxes	NULL
were	NULL
constructed	NULL
by	NULL
swapping	NULL
the	NULL
largest	NULL
fragment	NULL
either	NULL
from	NULL
Psfl	NULL
to	NULL
a	NULL
partially	NULL
digested	NULL
Apel	NULL
site	NULL
or	NULL
from	NULL
KpnI	NULL
to	NULL
a	NULL
partially	NULL
digested	NULL
Apel	NULL
site	NULL
between	NULL
the	NULL
constructs	NULL
described	NULL
above	NULL
.	NULL

For	NULL
generation	NULL
of	NULL
E-box	NULL
mutation	NULL
constructs	NULL
with	NULL
one	NULL
copy	NULL
of	NULL
the	NULL
99-bp	NULL
repeat	NULL
removed	NULL
,	NULL
an	NULL
Apal	NULL
fragment	NULL
was	NULL
removed	NULL
from	NULL
pE	NULL
(	NULL
c	NULL
)	NULL
CAT	NULL
,	NULL
pE	NULL
(	NULL
ab	NULL
)	NULL
CAT	NULL
,	NULL
and	NULL
pE	NULL
(	NULL
abe	NULL
)	NULL
CAT	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
specific	NULL
mutations	NULL
was	NULL
verified	NULL
by	NULL
using	NULL
an	NULL
Applied	NULL
Biosystem	NULL
Taq	NULL
sequencing	NULL
kit	NULL
on	NULL
an	NULL
Applied	NULL
Biosystem	NULL
373A	NULL
Sequencer	NULL
.	NULL

Expression	NULL
vectors	NULL
and	NULL
protein	NULL
purification	NULL
.	NULL

pBNALFIA	NULL
expressing	NULL
ALFL	NULL
under	NULL
control	NULL
of	NULL
the	NULL
EF-1	NULL
«	NULL
promoter	NULL
has	NULL
been	NULL
described	NULL
elsewhere	NULL
(	NULL
32	NULL
)	NULL
.	NULL

The	NULL
E12	NULL
and	NULL
E2-5	NULL
expression	NULL
vectors	NULL
were	NULL
kindly	NULL
donated	NULL
by	NULL
R.	NULL
Rivera	NULL
,	NULL
University	NULL
of	NULL
California	NULL
,	NULL
and	NULL
T.	NULL
Kadesch	NULL
,	NULL
University	NULL
of	NULL
Pennsylvania	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
respectively	NULL
.	NULL

Expression	NULL
vectors	NULL
pCMV4	NULL
and	NULL
pCMV4-Id1	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
and	NULL
were	NULL
kindly	NULL
donated	NULL
by	NULL
R.	NULL
Baer	NULL
,	NULL
University	NULL
of	NULL
Texas	NULL
Southwestern	NULL
Medical	NULL
Center	NULL
(	NULL
16	NULL
)	NULL
.	NULL

To	NULL
generate	NULL
the	NULL
prokaryotic	NULL
expression	NULL
construct	NULL
coding	NULL
for	NULL
ALF1	NULL
amino	NULL
acids	NULL
562	NULL
to	NULL
706	NULL
(	NULL
ALF1se	NULL
)	NULL
794	NULL
)	NULL
,	NULL
PCR	NULL
was	NULL
done	NULL
with	NULL
the	NULL
use	NULL
of	NULL
ALF1	NULL
primers	NULL
with	NULL
artificial	NULL
restriction	NULL
sites	NULL
followed	NULL
by	NULL
BerHI	NULL
and	NULL
EcoRI	NULL
cloning	NULL
of	NULL
the	NULL
generated	NULL
fragment	NULL
into	NULL
pGEX2TK	NULL
(	NULL
Pharmacia	NULL
)	NULL
.	NULL

The	NULL
prokaryotic	NULL
Id	NULL
expression	NULL
vector	NULL
was	NULL
generated	NULL
by	NULL
cloning	NULL
of	NULL
the	NULL
full-length	NULL
coding	NULL
region	NULL
of	NULL
Id1	NULL
into	NULL
pGEX2TK	NULL
by	NULL
use	NULL
of	NULL
artificial	NULL
restriction	NULL
sites	NULL
.	NULL

Induction	NULL
and	NULL
purification	NULL
procedures	NULL
for	NULL
the	NULL
glutathione	NULL
S-transferase	NULL
(	NULL
GST	NULL
)	NULL
fusion	NULL
proteins	NULL
were	NULL
as	NULL
described	NULL
by	NULL
the	NULL
manufacturer	NULL
(	NULL
Pharmacia	NULL
)	NULL
.	NULL

The	NULL
produced	NULL
GST-ALF1s	NULL
,	NULL
,	NULL
;	NULL
,	NULL
,	NULL
fusion	NULL
protein	NULL
was	NULL
digested	NULL
with	NULL
thrombin	NULL
and	NULL
purified	NULL
from	NULL
the	NULL
GST	NULL
moicty	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
and	NULL
antibodies	NULL
.	NULL

Cellular	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Double-stranded	NULL
34-nucleotide	NULL
oligonucleotide	NULL
probes	NULL
labeled	NULL
to	NULL
the	NULL
same	NULL
specific	NULL
activities	NULL
were	NULL
generated	NULL
as	NULL
J.	NULL
ViRoL	NULL
.	NULL

described	NULL
previously	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Binding	NULL
reactions	NULL
of	NULL
nuclear	NULL
extracts	NULL
with	NULL
2	NULL
x	NULL
10°	NULL
cpm	NULL
of	NULL
probe	NULL
were	NULL
done	NULL
at	NULL
25°C	NULL
for	NULL
15	NULL
min	NULL
in	NULL
25	NULL
wl	NULL
of	NULL
10	NULL
mM	NULL
HEPES	NULL
(	NULL
N-2	NULL
hydroxyethylpiperazine-V	NULL
'	NULL
-2-ethanesulfonic	NULL
acid	NULL
)	NULL
-NaOH	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
-10	NULL
mM	NULL
Tris-HCI	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
-3	NULL
mM	NULL
MgC1	NULL
,	NULL
-80	NULL
mM	NULL
NaCl-1	NULL
mM	NULL
dithiothreitol-300	NULL
ug	NULL
of	NULL
bovine	NULL
serum	NULL
albumin	NULL
per	NULL
ml	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
-poly	NULL
(	NULL
dI-dC	NULL
)	NULL
.	NULL

Prokaryotically	NULL
expressed	NULL
proteins	NULL
were	NULL
bound	NULL
under	NULL
the	NULL
same	NULL
conditions	NULL
except	NULL
for	NULL
the	NULL
addition	NULL
of	NULL
Tween	NULL
20	NULL
to	NULL
0.25	NULL
%	NULL
in	NULL
the	NULL
binding	NULL
buffer	NULL
and	NULL
preincubation	NULL
of	NULL
the	NULL
proteins	NULL
at	NULL
37°C	NULL
for	NULL
30	NULL
min	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
DNA	NULL
to	NULL
assist	NULL
heterodimer	NULL
formations	NULL
.	NULL

Following	NULL
binding	NULL
,	NULL
the	NULL
reaction	NULL
products	NULL
were	NULL
electrophoresed	NULL
through	NULL
native	NULL
gels	NULL
(	NULL
5	NULL
%	NULL
acrylamide	NULL
,	NULL
0.1	NULL
%	NULL
bisacrylamide	NULL
,	NULL
5	NULL
%	NULL
glycerol	NULL
,	NULL
50	NULL
mM	NULL
Tris	NULL
,	NULL
380	NULL
mM	NULL
glycine	NULL
,	NULL
2	NULL
mM	NULL
EDTA	NULL
)	NULL
and	NULL
autoradiographed	NULL
without	NULL
drying	NULL
at	NULL
-80°C	NULL
with	NULL
intensifying	NULL
screens	NULL
.	NULL

In	NULL
competition	NULL
analysis	NULL
,	NULL
a	NULL
50-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
oli-gonucleotides	NULL
was	NULL
added	NULL
together	NULL
with	NULL
the	NULL
probe	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
mixture	NULL
.	NULL

For	NULL
supershift	NULL
reactions	NULL
,	NULL
antiserum	NULL
and	NULL
control	NULL
serum	NULL
at	NULL
the	NULL
amounts	NULL
indicated	NULL
below	NULL
were	NULL
added	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
mixture	NULL
,	NULL
which	NULL
was	NULL
placed	NULL
on	NULL
ice	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
nuclear	NULL
extract	NULL
.	NULL

Polyclonal	NULL
ALF1	NULL
antibody	NULL
has	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
33	NULL
)	NULL
.	NULL

The	NULL
anti-HEB	NULL
antiserum	NULL
(	NULL
«	NULL
HEB	NULL
)	NULL
was	NULL
generated	NULL
by	NULL
immunizing	NULL
rabbits	NULL
with	NULL
HEB	NULL
amino	NULL
acids	NULL
530	NULL
to	NULL
554	NULL
,	NULL
a	NULL
sequence	NULL
region	NULL
100	NULL
%	NULL
identical	NULL
to	NULL
the	NULL
ALF	NULL
]	NULL
sequence	NULL
(	NULL
38	NULL
)	NULL
.	NULL

«	NULL
HEB	NULL
was	NULL
kindly	NULL
donated	NULL
by	NULL
D.	NULL
R.	NULL
Littman	NULL
,	NULL
University	NULL
of	NULL
California	NULL
.	NULL

The	NULL
anti-E2A	NULL
(	NULL
«	NULL
E2A	NULL
)	NULL
-specific	NULL
antiserum	NULL
was	NULL
obtained	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
.	NULL

Transfections	NULL
and	NULL
CAT	NULL
assays	NULL
.	NULL

NIH	NULL
3T3	NULL
cells	NULL
(	NULL
5	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
transfected	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Each	NULL
precipitate	NULL
included	NULL
2	NULL
ug	NULL
of	NULL
CAT	NULL
reporter	NULL
plasmid	NULL
,	NULL
2.0	NULL
pg	NULL
of	NULL
expression	NULL
vector	NULL
,	NULL
and	NULL
5	NULL
pg	NULL
of	NULL
pCH110	NULL
as	NULL
an	NULL
internal	NULL
standard	NULL
expressing	NULL
B-galactosidase	NULL
from	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
promoter	NULL
.	NULL

CAT	NULL
assays	NULL
were	NULL
done	NULL
for	NULL
0.5	NULL
to	NULL
4	NULL
h	NULL
,	NULL
and	NULL
conversions	NULL
were	NULL
monitored	NULL
by	NULL
scintillation	NULL
counting	NULL
or	NULL
by	NULL
PhosphorImager	NULL
analyses	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
)	NULL
of	NULL
thin-layer	NULL
chromato-grams	NULL
.	NULL

Estimated	NULL
values	NULL
were	NULL
normalized	NULL
to	NULL
the	NULL
B-galactosidase	NULL
activities	NULL
to	NULL
correct	NULL
for	NULL
variation	NULL
in	NULL
transfection	NULL
efficiency	NULL
.	NULL

Transfections	NULL
of	NULL
Mpc11	NULL
and	NULL
K562	NULL
cells	NULL
were	NULL
done	NULL
as	NULL
for	NULL
NIH	NULL
3T3	NULL
cells	NULL
except	NULL
that	NULL
the	NULL
plates	NULL
were	NULL
seeded	NULL
with	NULL
3	NULL
X	NULL
10°	NULL
cells	NULL
per	NULL
100-mm-diameter	NULL
plate	NULL
24	NULL
h	NULL
before	NULL
transfection	NULL
.	NULL

DNA	NULL
concentrations	NULL
were	NULL
5	NULL
ug	NULL
of	NULL
CAT	NULL
reporter	NULL
plasmid	NULL
,	NULL
5	NULL
ug	NULL
of	NULL
pCH110	NULL
,	NULL
and	NULL
6	NULL
ug	NULL
of	NULL
cytomegalovirus	NULL
4	NULL
expression	NULL
vector	NULL
.	NULL

1691-6	NULL
and	NULL
J558L	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
DEAE-dextran	NULL
as	NULL
described	NULL
previously	NULL
,	NULL
with	NULL
modifications	NULL
(	NULL
40	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
suspended	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
TSD	NULL
(	NULL
140	NULL
mM	NULL
NaCl	NULL
,	NULL
5	NULL
mM	NULL
KC	NULL
,	NULL
0.6	NULL
mM	NULL
Na	NULL
,	NULL
HPO	NULL
,	NULL
,	NULL
25	NULL
mM	NULL
Tris	NULL
base	NULL
[	NULL
pH	NULL
7.4	NULL
]	NULL
,	NULL
0.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.7	NULL
mM	NULL
CaCl	NULL
,	NULL
,	NULL
0.5	NULL
mg	NULL
of	NULL
DEAE-dextran	NULL
[	NULL
Pharmacia	NULL
]	NULL
)	NULL
including	NULL
5	NULL
pg	NULL
of	NULL
CAT	NULL
reporter	NULL
plasmid	NULL
and	NULL
additionally	NULL
,	NULL
in	NULL
cotransfection	NULL
experiments	NULL
,	NULL
5	NULL
pg	NULL
of	NULL
cytomegalovirus	NULL
expression	NULL
vector	NULL
.	NULL

After	NULL
incubation	NULL
for	NULL
20	NULL
min	NULL
at	NULL
37°C	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
complete	NULL
medium	NULL
and	NULL
incubated	NULL
for	NULL
48	NULL
h.	NULL
Cellular	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
CAT	NULL
activity	NULL
was	NULL
measured	NULL
as	NULL
for	NULL
the	NULL
NIH	NULL
3T3	NULL
cells	NULL
except	NULL
that	NULL
the	NULL
extracts	NULL
were	NULL
preincubated	NULL
at	NULL
60°C	NULL
for	NULL
10	NULL
min	NULL
and	NULL
centrifuged	NULL
before	NULL
the	NULL
CAT	NULL
assay	NULL
.	NULL

CAT	NULL
conversion	NULL
was	NULL
normalized	NULL
to	NULL
the	NULL
total	NULL
protein	NULL
concentration	NULL
,	NULL
and	NULL
all	NULL
transfections	NULL
were	NULL
repeated	NULL
three	NULL
to	NULL
nine	NULL
times	NULL
.	NULL

RESULTS	NULL
Several	NULL
distinct	NULL
protein	NULL
complexes	NULL
interact	NULL
with	NULL
the	NULL
MLV	NULL
E-boxes	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
sequences	NULL
within	NULL
the	NULL
U3	NULL
part	NULL
of	NULL
Akv	NULL
and	NULL
SL3-3	NULL
MLV	NULL
LTRs	NULL
are	NULL
determinants	NULL
for	NULL
transcriptional	NULL
activity	NULL
(	NULL
6	NULL
,	NULL
12	NULL
,	NULL
25	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
consensus	NULL
E-box	NULL
motifs	NULL
(	NULL
CANNTG	NULL
)	NULL
were	NULL
identified	NULL
in	NULL
SL3-3	NULL
MLV	NULL
and	NULL
Akv	NULL
MLV	NULL
U3	NULL
regions	NULL
(	NULL
9	NULL
,	NULL
31	NULL
,	NULL
32	NULL
)	NULL
.	NULL

The	NULL
U3	NULL
region	NULL
of	NULL
Akvy	NULL
MLV	NULL
contains	NULL
three	NULL
E-box	NULL
consensus	NULL
motifs	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

and	NULL
E	NULL
,	NULL
,	NULL
(	NULL
B	NULL
)	NULL
in	NULL
the	NULL
tandem	NULL
repeat	NULL
are	NULL
identical	NULL
with	NULL
the	NULL
sequence	NULL
AACAGATGGT	NULL
;	NULL
the	NULL
E	NULL
,	NULL
,	NULL
,	NULL
sequence	NULL
overlaps	NULL
the	NULL
glucocorticoid	NULL
response	NULL
element	NULL
.	NULL

Ea,4	NULL
(	NULL
C	NULL
)	NULL
(	NULL
CCCAGATGAC	NULL
)	NULL
is	NULL
located	NULL
between	NULL
the	NULL
tandem	NULL
enhancer	NULL
repeat	NULL
and	NULL
the	NULL
promoter	NULL
region	NULL
.	NULL

The	NULL
SL3-3	NULL
MLV	NULL
U3	NULL
region	NULL
contains	NULL
a	NULL
triplicated	NULL
region	NULL
carrying	NULL
the	NULL
E	NULL
,	NULL
,	NULL
,	NULL
E-box	NULL
and	NULL
an	NULL
Ep	NULL
,	NULL
in	NULL
the	NULL
upstream	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
binding	NULL
of	NULL
cellular	NULL
proteins	NULL
to	NULL
the	NULL
sequence	NULL
regions	NULL
corresponding	NULL
to	NULL
the	NULL
E-boxes	NULL
,	NULL
we	NULL
did	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
using	NULL
oligonucleotide	NULL
probes	NULL
with	NULL
the	NULL
Akv	NULL
MLV	NULL
and	NULL
SL3-3	NULL
MLV	NULL
E-box	NULL
sequence	NULL
E	NULL
,	NULL
,	NULL
,	NULL
Or	NULL
Ex	NULL
,	NULL
s	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

We	NULL
have	NULL
analyzed	NULL
nuclear	NULL
extracts	NULL
from	NULL
T-cell	NULL
lines	NULL
(	NULL
L691-6	NULL
and	NULL
WEHI7.1	NULL
)	NULL
,	NULL
a	NULL
B-cell	NULL
line	NULL
(	NULL
J558L	NULL
)	NULL
,	NULL
and	NULL
a	NULL
fibroblast	NULL
cell	NULL
line	NULL
(	NULL
NIH	NULL
3T3	NULL
)	NULL
for	NULL
their	NULL
ability	NULL
to	NULL
form	NULL
complexes	NULL
with	NULL
affinity	NULL
for	NULL
the	NULL
E-box	NULL
sequences	NULL
.	NULL

All	NULL
major	NULL
bands	NULL
were	NULL
specific	NULL
for	NULL
the	NULL
E-box	NULL
sequences	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
they	NULL
were	NULL
not	NULL
formed	NULL
with	NULL
oligonucleo-tides	NULL
including	NULL
a	NULL
mutated	NULL
E-box	NULL
sequence	NULL
such	NULL
as	NULL
AANNTG	NULL
(	NULL
mutated	NULL
nucleotide	NULL
underlined	NULL
)	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

When	NULL
the	NULL
E	NULL
,	NULL
,	NULL
,	NULL
oligonucleotide	NULL
probe	NULL
was	NULL
used	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
T-and	NULL
B-cell	NULL
lines	NULL
formed	NULL
E-box-specific	NULL
complexes	NULL
termed	NULL
nu	NULL
VoL	NULL
.	NULL

70	NULL
,	NULL
1996	NULL
[	NULL
us	NULL
[	NULL
R	NULL
_|	NULL
U5	NULL
|_	NULL
Leader	NULL
_|	NULL
cat	NULL
|	NULL
Egre	NULL
(	NULL
A	NULL
)	NULL
Em	NULL
|___	NULL
___	NULL
___	NULL
]	NULL
pakvecat	NULL
482	NULL
371	NULL
«	NULL
272	NULL
173	NULL
+1	NULL
|	NULL
Egre	NULL
(	NULL
A	NULL
)	NULL
Egre	NULL
{	NULL
B	NULL
)	NULL
___	NULL
BRAT	NULL
___	NULL
]	NULL
pegcat	NULL
482	NULL
371	NULL
«	NULL
272	NULL
173	NULL
+1	NULL
_	NULL
Ee	NULL
(	NULL
A	NULL
)	NULL
EAIS	NULL
(	NULL
C	NULL
)	NULL
pE	NULL
(	NULL
b	NULL
)	NULL
CAT	NULL
482	NULL
«	NULL
371	NULL
-Z72	NULL
173	NULL
+1	NULL
Egre	NULL
(	NULL
B	NULL
)	NULL
EA/S	NULL
(	NULL
C	NULL
)	NULL
-__-	NULL
pE	NULL
(	NULL
@	NULL
)	NULL
CAT	NULL
482	NULL
371	NULL
272	NULL
173	NULL
Lal	NULL
-§§§ﬁ	NULL
%	NULL
§	NULL
%	NULL
§§	NULL
;	NULL
§§	NULL
%	NULL
‘	NULL
ﬁi—	NULL
pE	NULL
(	NULL
ab	NULL
)	NULL
CAT	NULL
482	NULL
«	NULL
371	NULL
«	NULL
272	NULL
~173	NULL
Egre	NULL
(	NULL
B	NULL
)	NULL
~~	NULL
TTT	NULL
recocar	NULL
482	NULL
«	NULL
371	NULL
272	NULL
173	NULL
+1	NULL
Egre	NULL
(	NULL
A	NULL
)	NULL
~~	NULL
TTT	NULL
)	NULL
revocat	NULL
482	NULL
+371	NULL
272	NULL
173	NULL
+4	NULL
-§ﬁﬁiﬂs§	NULL
%	NULL
§sﬁmﬁiﬁ§—	NULL
pE	NULL
(	NULL
bc	NULL
)	NULL
CAT	NULL
482	NULL
371	NULL
«	NULL
272	NULL
173	NULL
Egre	NULL
(	NULL
B	NULL
)	NULL
EAS	NULL
(	NULL
C	NULL
)	NULL
p1-99CAT	NULL
+383	NULL
272	NULL
173	NULL
+14	NULL
___	NULL
:	NULL
_-_	NULL
BRR	NULL
___________	NULL
]	NULL
riecat	NULL
383	NULL
272	NULL
173	NULL
+1	NULL
_	NULL
-	NULL
EAiS	NULL
(	NULL
C	NULL
)	NULL
___	NULL
BSR	NULL
__________	NULL
]	NULL
pmepcat	NULL
«	NULL
383	NULL
272	NULL
+173	NULL
+1	NULL
~~	NULL
BEER	NULL
-	NULL
]	NULL
mepocat	NULL
+383	NULL
+272	NULL
173	NULL
+14	NULL
Egre	NULL
Egre	NULL
Egre	NULL
EA/S	NULL
_	NULL
%	NULL
§§§§é§¥ﬁ§§	NULL
%	NULL
_	NULL
pSL3-3CAT	NULL
481	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Structure	NULL
of	NULL
MLV	NULL
LTR	NULL
CAT	NULL
gene	NULL
constructs	NULL
.	NULL

In	NULL
the	NULL
pAKV6CAT	NULL
construct	NULL
,	NULL
the	NULL
CAT	NULL
reporter	NULL
gene	NULL
was	NULL
set	NULL
under	NULL
transcriptional	NULL
control	NULL
of	NULL
the	NULL
Aky	NULL
MLV	NULL
LTR	NULL
and	NULL
flanking	NULL
sequences	NULL
.	NULL

The	NULL
pSL3-3CAT	NULL
construct	NULL
was	NULL
generated	NULL
by	NULL
replacing	NULL
the	NULL
Akvy	NULL
MLV	NULL
U3	NULL
region	NULL
with	NULL
the	NULL
SL3-3	NULL
MLV	NULL
U3	NULL
region	NULL
.	NULL

p1-99CAT	NULL
was	NULL
derived	NULL
from	NULL
pAKV6CAT	NULL
by	NULL
removing	NULL
one	NULL
copy	NULL
of	NULL
the	NULL
enhancer	NULL
repeat	NULL
.	NULL

By	NULL
PCR	NULL
,	NULL
the	NULL
mutation	NULL
AAGATG	NULL
was	NULL
introduced	NULL
into	NULL
each	NULL
E-box	NULL
(	NULL
CA	NULL
GATG	NULL
)	NULL
,	NULL
and	NULL
all	NULL
possible	NULL
combinations	NULL
of	NULL
E-box	NULL
mutations	NULL
were	NULL
created	NULL
in	NULL
the	NULL
background	NULL
of	NULL
pAKV6CAT	NULL
or	NULL
p1-99CAT	NULL
.	NULL

Introduced	NULL
E-box	NULL
mutations	NULL
(	NULL
-	NULL
)	NULL
and	NULL
enhancer	NULL
repeat	NULL
structures	NULL
(	NULL
shaded	NULL
boxes	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

Numbers	NULL
of	NULL
nucleotides	NULL
are	NULL
given	NULL
below	NULL
the	NULL
boxes	NULL
,	NULL
with	NULL
+1	NULL
corresponding	NULL
to	NULL
the	NULL
start	NULL
point	NULL
of	NULL
transcription	NULL
.	NULL

351	NULL
«	NULL
317	NULL
+245	NULL
+173	NULL
clear	NULL
factor	NULL
complexes	NULL
(	NULL
NFC	NULL
,	NULL
,	NULL
\s	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

The	NULL
intensities	NULL
of	NULL
the	NULL
bands	NULL
varied	NULL
for	NULL
the	NULL
different	NULL
cell	NULL
types	NULL
;	NULL
NFC	NULL
,	NULL
,	NULL
_4	NULL
was	NULL
always	NULL
the	NULL
most	NULL
prominent	NULL
band	NULL
,	NULL
whereas	NULL
NFC	NULL
,	NULL
,	NULL
,2	NULL
and	NULL
NF-C	NULL
,	NULL
,	NULL
.	NULL

were	NULL
barely	NULL
detectable	NULL
in	NULL
WEHI7.1	NULL
cells	NULL
.	NULL

The	NULL
E-box	NULL
specificity	NULL
of	NULL
the	NULL
bands	NULL
was	NULL
verified	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
competition	NULL
analysis	NULL
with	NULL
mutant	NULL
E-box	NULL
probes	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

E-box-specific	NULL
complexes	NULL
termed	NULL
nuclear	NULL
factor	NULL
complexes	NULL
(	NULL
NFC	NULL
,	NULL
,	NULL
;	NULL
s	NULL
)	NULL
were	NULL
formed	NULL
with	NULL
the	NULL
E	NULL
,	NULL
,	NULL
,	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
lymphocytic	NULL
cell	NULL
lines	NULL
,	NULL
E-box-interacting	NULL
protein	NULL
complexes	NULL
include	NULL
ALF1	NULL
or	NULL
HEB	NULL
and	NULL
ALF2	NULL
or	NULL
E2A	NULL
subunits	NULL
.	NULL

To	NULL
examine	NULL
if	NULL
the	NULL
identified	NULL
E-box-specific	NULL
protein	NULL
complexes	NULL
formed	NULL
with	NULL
the	NULL
oligonucleotide	NULL
probes	NULL
E	NULL
,	NULL
,	NULL
,	NULL
and	NULL
E	NULL
,	NULL
,	NULL
,	NULL
included	NULL
class	NULL
A	NULL
bHLH	NULL
components	NULL
,	NULL
we	NULL
did	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
,	NULL
using	NULL
polyclonal	NULL
antisera	NULL
raised	NULL
against	NULL
either	NULL
ALF1	NULL
or	NULL
the	NULL
murine	NULL
EZA	NULL
protein	NULL
ALF2	NULL
.	NULL

Binding	NULL
of	NULL
nuclear	NULL
bHLH	NULL
PROTEINS	NULL
REGULATE	NULL
MLV	NULL
TRANSCRIPTION	NULL
5895	NULL
extracts	NULL
from	NULL
T-cell	NULL
lines	NULL
(	NULL
L691-6	NULL
or	NULL
WEHI7.1	NULL
)	NULL
and	NULL
a	NULL
B-cell	NULL
line	NULL
(	NULL
J558L	NULL
)	NULL
to	NULL
the	NULL
E	NULL
,	NULL
,	NULL
,	NULL
oligonuclcotide	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
ALF1	NULL
antiserum	NULL
showed	NULL
a	NULL
decrease	NULL
in	NULL
formation	NULL
of	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

With	NULL
the	NULL
ALF2-E2A	NULL
antiserum	NULL
,	NULL
we	NULL
observed	NULL
the	NULL
same	NULL
pattern	NULL
but	NULL
more	NULL
pronounced	NULL
.	NULL

In	NULL
this	NULL
case	NULL
,	NULL
NFC	NULL
,	NULL
,	NULL
1	NULL
was	NULL
completely	NULL
undetectable	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
antiserum	NULL
.	NULL

In	NULL
NIH	NULL
3T3	NULL
cells	NULL
,	NULL
none	NULL
of	NULL
the	NULL
E-box	NULL
complexes	NULL
reacted	NULL
with	NULL
the	NULL
antisera	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
previous	NULL
observations	NULL
that	NULL
NIH	NULL
3T3	NULL
fibroblasts	NULL
are	NULL
depleted	NULL
of	NULL
DNA-binding	NULL
class	NULL
A	NULL
bHLH	NULL
proteins	NULL
(	NULL
32	NULL
,	NULL
38	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
two	NULL
antibodies	NULL
su-pershifted	NULL
none	NULL
of	NULL
the	NULL
complexes	NULL
formed	NULL
with	NULL
the	NULL
E	NULL
,	NULL
,	NULL
,	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
ALF1	NULL
and	NULL
ALF2	NULL
or	NULL
EZA	NULL
are	NULL
not	NULL
involved	NULL
in	NULL
complex	NULL
formation	NULL
at	NULL
the	NULL
E-box	NULL
sequence	NULL
Ex	NULL
,	NULL
g	NULL
,	NULL
localized	NULL
between	NULL
the	NULL
enhancer	NULL
and	NULL
the	NULL
promoter	NULL
regions	NULL
in	NULL
both	NULL
Akv	NULL
and	NULL
SL3-3	NULL
MLVs	NULL
.	NULL

As	NULL
ALFI	NULL
and	NULL
ALF2	NULL
or	NULL
EZA	NULL
are	NULL
very	NULL
homologous	NULL
in	NULL
primary	NULL
structure	NULL
,	NULL
the	NULL
polyclonal	NULL
sera	NULL
for	NULL
ALF1	NULL
and	NULL
ALF2/EZA	NULL
were	NULL
found	NULL
to	NULL
cross-react	NULL
to	NULL
some	NULL
degree	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

There-fore	NULL
,	NULL
we	NULL
repeated	NULL
our	NULL
examinations	NULL
with	NULL
sera	NULL
more	NULL
specific	NULL
for	NULL
each	NULL
component	NULL
.	NULL

«	NULL
HEB	NULL
reacts	NULL
with	NULL
a	NULL
domain	NULL
specific	NULL
for	NULL
ALF1	NULL
or	NULL
HEB	NULL
,	NULL
and	NULL
«	NULL
E2A	NULL
reacts	NULL
specifically	NULL
with	NULL
the	NULL
ALF2	NULL
or	NULL
E2A	NULL
proteins	NULL
(	NULL
38	NULL
)	NULL
.	NULL

«	NULL
HEB	NULL
decreased	NULL
the	NULL
mobility	NULL
of	NULL
NFC	NULL
,	NULL
,	NULL
.1	NULL
from	NULL
the	NULL
T-cell	NULL
lines	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

Nuclear	NULL
extract	NULL
from	NULL
the	NULL
B-cell	NULL
line	NULL
J558L	NULL
includes	NULL
an	NULL
«	NULL
HEB-retarded	NULL
complex	NULL
comigrating	NULL
with	NULL
the	NULL
«	NULL
HEB-retarded	NULL
complexes	NULL
from	NULL
the	NULL
T-cell	NULL
lines	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

Hence	NULL
,	NULL
NFC	NULL
,	NULL
,	NULL
includes	NULL
ALF1	NULL
or	NULL
HEB	NULL
subunits	NULL
.	NULL

Incubation	NULL
with	NULL
«	NULL
EZA	NULL
antiserum	NULL
always	NULL
completely	NULL
removed	NULL
the	NULL
NFC	NULL
,	NULL
,	NULL
,1	NULL
(	NULL
Fig	NULL
.	NULL

2D	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
all	NULL
tested	NULL
T-	NULL
and	NULL
B-cell	NULL
lines	NULL
,	NULL
NFCgrel	NULL
includes	NULL
E2A	NULL
subunits	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
class	NULL
A	NULL
bHLH	NULL
protein	NULL
complexes	NULL
of	NULL
B-	NULL
and	NULL
T-cell	NULL
lines	NULL
include	NULL
both	NULL
ALF1	NULL
and	NULL
EZA	NULL
subunits	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
E	NULL
,	NULL
,	NULL
,	NULL
motif	NULL
but	NULL
not	NULL
to	NULL
the	NULL
very	NULL
homologous	NULL
Ea	NULL
,	NULL
.	NULL

Since	NULL
nuclear	NULL
extracts	NULL
from	NULL
lymphoid	NULL
cell	NULL
lines	NULL
contained	NULL
DNA-binding	NULL
ALF1	NULL
and	NULL
ALF2	NULL
or	NULL
E2A	NULL
bHLH	NULL
proteins	NULL
,	NULL
we	NULL
did	NULL
transient-transfection	NULL
assays	NULL
to	NULL
examine	NULL
the	NULL
transcriptional	NULL
regulatory	NULL
capacity	NULL
of	NULL
various	NULL
combinations	NULL
of	NULL
ALF1	NULL
and	NULL
ALF2	NULL
or	NULL
E2A	NULL
proteins	NULL
.	NULL

We	NULL
cotransfected	NULL
into	NULL
NIH	NULL
3T3	NULL
cells	NULL
the	NULL
pAKV6CAT	NULL
construct	NULL
,	NULL
having	NULL
the	NULL
CAT	NULL
gene	NULL
under	NULL
transcriptional	NULL
control	NULL
of	NULL
the	NULL
Akv	NULL
MLV	NULL
LTR	NULL
with	NULL
expression	NULL
vectors	NULL
for	NULL
the	NULL
bHLH	NULL
proteins	NULL
.	NULL

Both	NULL
ALF1	NULL
and	NULL
E2A	NULL
proteins	NULL
activated	NULL
pAKV6CAT	NULL
transcription	NULL
approximately	NULL
fourfold	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Cotransfection	NULL
of	NULL
ALF1	NULL
and	NULL
E2A	NULL
proteins	NULL
showed	NULL
no	NULL
syn-ergistically	NULL
transactivated	NULL
transcription	NULL
from	NULL
the	NULL
Akvy	NULL
MLV	NULL
enhancer	NULL
to	NULL
the	NULL
same	NULL
level	NULL
as	NULL
the	NULL
putative	NULL
heterodimeric	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

We	NULL
should	NULL
draw	NULL
attention	NULL
to	NULL
the	NULL
fact	NULL
that	NULL
homodimeric	NULL
ALF1	NULL
or	NULL
HEB	NULL
and	NULL
EZ2A	NULL
proteins	NULL
have	NULL
different	NULL
preferred	NULL
DNA-binding	NULL
sites	NULL
(	NULL
5	NULL
,	NULL
42	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
ALF1	NULL
and	NULL
E2A	NULL
proteins	NULL
require	NULL
different	NULL
compositions	NULL
of	NULL
enhancer	NULL
E-boxes	NULL
for	NULL
mediating	NULL
transcriptional	NULL
activity	NULL
(	NULL
see	NULL
below	NULL
and	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

We	NULL
find	NULL
E-box-binding	NULL
complexes	NULL
without	NULL
ALF1	NULL
and	NULL
ALF2	NULL
or	NULL
EZ2A	NULL
proteins	NULL
.	NULL

Similar	NULL
observations	NULL
have	NULL
been	NULL
made	NULL
in	NULL
other	NULL
studies	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
ubiquitous	NULL
protein	NULL
complexes	NULL
lacking	NULL
class	NULL
A	NULL
bHLH	NULL
protein	NULL
interact	NULL
with	NULL
the	NULL
CD4	NULL
enhancer	NULL
E-box	NULL
(	NULL
38	NULL
)	NULL
.	NULL

We	NULL
do	NULL
not	NULL
relate	NULL
these	NULL
E-box-binding	NULL
protein	NULL
complexes	NULL
,	NULL
without	NULL
ALF1	NULL
and	NULL
ALF2	NULL
or	NULL
E2A	NULL
proteins	NULL
,	NULL
to	NULL
any	NULL
DNA-binding	NULL
protein	NULL
family	NULL
,	NULL
but	NULL
they	NULL
could	NULL
make	NULL
up	NULL
transcription	NULL
factor	NULL
complexes	NULL
.	NULL

Notably	NULL
,	NULL
the	NULL
transcriptional	NULL
activity	NULL
mediated	NULL
by	NULL
protein	NULL
complexes	NULL
formed	NULL
on	NULL
the	NULL
Ea	NULL
,	NULL
,	NULL
could	NULL
not	NULL
be	NULL
repressed	NULL
by	NULL
ectopic	NULL
expression	NULL
of	NULL
Id1	NULL
(	NULL
see	NULL
below	NULL
and	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

MLV	NULL
E-boxes	NULL
are	NULL
weak	NULL
transcriptional	NULL
elements	NULL
in	NULL
NIH	NULL
3T3	NULL
and	NULL
HeLa	NULL
cells	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
contribution	NULL
from	NULL
individual	NULL
E-box	NULL
sequences	NULL
to	NULL
the	NULL
MLV	NULL
enhancer	NULL
function	NULL
,	NULL
by	NULL
PCR	NULL
we	NULL
introduced	NULL
identical	NULL
point	NULL
mutations	NULL
into	NULL
each	NULL
of	NULL
the	NULL
three	NULL
Aky	NULL
MLV	NULL
E-boxes	NULL
and	NULL
created	NULL
constructs	NULL
with	NULL
all	NULL
possible	NULL
combinations	NULL
of	NULL
wild-type	NULL
and	NULL
mutated	NULL
E-box	NULL
motifs	NULL
.	NULL

The	NULL
in	NULL
5896	NULL
NIELSEN	NULL
ET	NULL
AL	NULL
.	NULL

WEHI	NULL
-	NULL
L691	NULL
-	NULL
J558L	NULL
NIH3T3	NULL
A	NULL
1	NULL
-	NULL
»	NULL
2—	NULL
>	NULL
3—D	NULL
a	NULL
-	NULL
»	NULL
WW	NULL
can	NULL
can	NULL
5	NULL
-	NULL
»	NULL
NF	NULL
Cs..	NULL
Complexes	NULL
100	NULL
20	NULL
3	NULL
140	NULL
20	NULL
3	NULL
140	NULL
2	NULL
3	NULL
140	NULL
203	NULL
WEHI	NULL
-	NULL
L691	NULL
_	NULL
J558L	NULL
NIH3T3	NULL
B	NULL
C	NULL
WEHI__L6gi	NULL
_	NULL
J558L	NULL
NIH3T3	NULL
pee	NULL
poate	NULL
Soe	NULL
Soe	NULL
r	NULL
t	NULL
s	NULL
I	NULL
a	NULL
``	NULL
o-	NULL
»	NULL
1	NULL
»	NULL
9	NULL
-	NULL
»	NULL
3	NULL
-	NULL
»	NULL
Mew	NULL
._	NULL
NFCg3re	NULL
Complexes	NULL
102	NULL
40	NULL
20	NULL
14	NULL
2001	NULL
2	NULL
WEHI_	NULL
L691	NULL
_	NULL
J558L	NULL
NIH3T3	NULL
oe	NULL
perce	NULL
pom	NULL
WO	NULL
male	NULL
o	NULL
3	NULL
»	NULL
1	NULL
-	NULL
>	NULL
*	NULL
9	NULL
-	NULL
»	NULL
3	NULL
-	NULL
»	NULL
4	NULL
-	NULL
»	NULL
1°	NULL
2	NULL
1	NULL
2	NULL
1	NULL
2	NULL
1	NULL
2	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

E.	NULL
,	NULL
,	NULL
-binding	NULL
protein	NULL
complexes	NULL
include	NULL
ALF1	NULL
and	NULL
E2A	NULL
subunits	NULL
.	NULL

(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
reaction	NULL
mixtures	NULL
included	NULL
nuclear	NULL
extracts	NULL
,	NULL
rabbit	NULL
antiserum	NULL
against	NULL
ALF	NULL
]	NULL
(	NULL
«	NULL
ALF1	NULL
)	NULL
or	NULL
E2A	NULL
proteins	NULL
(	NULL
«	NULL
ALF2	NULL
)	NULL
,	NULL
and	NULL
the	NULL
E.	NULL
,	NULL
,	NULL
probe	NULL
(	NULL
A	NULL
)	NULL
or	NULL
the	NULL
Ey	NULL
,	NULL
probe	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Lanes	NULL
1	NULL
,	NULL
1	NULL
jl	NULL
of	NULL
a	NULL
10-fold	NULL
dilution	NULL
of	NULL
preimmune	NULL
serum	NULL
;	NULL
lanes	NULL
2	NULL
,	NULL
1	NULL
pl	NULL
of	NULL
a	NULL
10-fold	NULL
dilution	NULL
of	NULL
«	NULL
ALF1	NULL
;	NULL
and	NULL
lanes	NULL
3	NULL
,	NULL
1	NULL
pl	NULL
of	NULL
a	NULL
10-fold	NULL
dilution	NULL
of	NULL
«	NULL
ALF2	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
the	NULL
F	NULL
...	NULL
.	NULL

,	NULL
-specific	NULL
complexes	NULL
NFC	NULL
,	NULL
,	NULL
are	NULL
indicated	NULL
.	NULL

(	NULL
C	NULL
and	NULL
D	NULL
)	NULL
Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
with	NULL
ALF1-HEB-specific	NULL
antibody	NULL
«	NULL
HEB	NULL
and	NULL
ALF2-E2A-specific	NULL
antibody	NULL
«	NULL
E2A	NULL
,	NULL
respectively	NULL
.	NULL

Reaction	NULL
mixtures	NULL
included	NULL
nuclear	NULL
extracts	NULL
,	NULL
the	NULL
E	NULL
,	NULL
,	NULL
,	NULL
oligonucleo-tide	NULL
,	NULL
and	NULL
either	NULL
unspecific	NULL
serum	NULL
(	NULL
lanes	NULL
1	NULL
)	NULL
or	NULL
specific	NULL
antiserum	NULL
(	NULL
lanes	NULL
2	NULL
)	NULL
.	NULL

J.	NULL
ViRoL	NULL
.	NULL

500	NULL
Normalized	NULL
CAT	NULL
activity	NULL
100	NULL
0	NULL
T	NULL
T	NULL
T	NULL
T	NULL
+ALF1	NULL
+E2A	NULL
+ALF1	NULL
,	NULL
+E2A	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

ALFI	NULL
and	NULL
E2A	NULL
proteins	NULL
do	NULL
not	NULL
activate	NULL
Aky	NULL
MLV	NULL
transcription	NULL
synergistically	NULL
.	NULL

The	NULL
pAKV6CAT	NULL
construct	NULL
(	NULL
2	NULL
ug	NULL
)	NULL
was	NULL
cotransfected	NULL
into	NULL
NIH	NULL
3T3	NULL
cells	NULL
(	NULL
5	NULL
X	NULL
10°	NULL
)	NULL
with	NULL
a	NULL
total	NULL
of	NULL
2	NULL
ug	NULL
of	NULL
expression	NULL
vector	NULL
,	NULL
either	NULL
parental	NULL
empty	NULL
expression	NULL
vectors	NULL
(	NULL
basal	NULL
)	NULL
,	NULL
vector	NULL
expressing	NULL
ALF1	NULL
(	NULL
encoding	NULL
expression	NULL
vectors	NULL
pBNALF1A	NULL
and	NULL
pBNALF1B	NULL
)	NULL
or	NULL
E2A	NULL
(	NULL
protein-encoding	NULL
expression	NULL
vectors	NULL
E47	NULL
and	NULL
E2-5	NULL
)	NULL
,	NULL
or	NULL
ALF	NULL
]	NULL
and	NULL
EZA	NULL
expression	NULL
vectors	NULL
in	NULL
combinations	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

A	NULL
2-g	NULL
amount	NULL
of	NULL
expression	NULL
vector	NULL
yields	NULL
half-saturation	NULL
of	NULL
the	NULL
synthesis	NULL
,	NULL
as	NULL
measured	NULL
by	NULL
either	NULL
ALF1	NULL
or	NULL
E2A	NULL
expression	NULL
.	NULL

Five	NULL
micrograms	NULL
of	NULL
pCH110	NULL
was	NULL
included	NULL
as	NULL
an	NULL
internal	NULL
standard	NULL
expressing	NULL
B-galactosidase	NULL
from	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
promoter	NULL
.	NULL

The	NULL
B-galactosidase-normalized	NULL
CAT	NULL
activities	NULL
were	NULL
estimated	NULL
and	NULL
visualized	NULL
by	NULL
setting	NULL
the	NULL
value	NULL
of	NULL
the	NULL
basal	NULL
expression	NULL
to	NULL
100	NULL
.	NULL

The	NULL
standard	NULL
deviation	NULL
from	NULL
the	NULL
mean	NULL
values	NULL
was	NULL
=25	NULL
%	NULL
.	NULL

Basal	NULL
activity	NULL
troduced	NULL
mutation	NULL
changed	NULL
the	NULL
E-box	NULL
core	NULL
sequence	NULL
CAG	NULL
ATG	NULL
to	NULL
AAGATG	NULL
,	NULL
a	NULL
mutation	NULL
found	NULL
to	NULL
eliminate	NULL
the	NULL
binding	NULL
of	NULL
class	NULL
A	NULL
bHLH	NULL
proteins	NULL
in	NULL
vitro	NULL
and	NULL
transactivation	NULL
in	NULL
vivo	NULL
(	NULL
32	NULL
)	NULL
.	NULL

The	NULL
panel	NULL
of	NULL
constructs	NULL
generated	NULL
is	NULL
shown	NULL
schematically	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

According	NULL
to	NULL
the	NULL
nomenclature	NULL
of	NULL
Speck	NULL
et	NULL
al	NULL
.	NULL

(	NULL
40	NULL
)	NULL
,	NULL
the	NULL
mutated	NULL
E-boxes	NULL
are	NULL
shown	NULL
in	NULL
parentheses	NULL
[	NULL
e.g	NULL
.	NULL

,	NULL
pE	NULL
(	NULL
ab	NULL
)	NULL
CAT	NULL
includes	NULL
mutations	NULL
in	NULL
E	NULL
,	NULL
,	NULL
,	NULL
(	NULL
A	NULL
)	NULL
and	NULL
E	NULL
,	NULL
,	NULL
,	NULL
(	NULL
B	NULL
)	NULL
]	NULL
.	NULL

Studies	NULL
of	NULL
Aky	NULL
MLV	NULL
transcriptional	NULL
regulation	NULL
in	NULL
NIH	NULL
3T3	NULL
fibroblast	NULL
cells	NULL
have	NULL
shown	NULL
that	NULL
removal	NULL
of	NULL
one	NULL
copy	NULL
of	NULL
the	NULL
99-bp	NULL
enhancer	NULL
repeat	NULL
reduced	NULL
the	NULL
transcriptional	NULL
activity	NULL
(	NULL
25	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
function	NULL
of	NULL
E-boxes	NULL
in	NULL
enhancers	NULL
with	NULL
only	NULL
one	NULL
copy	NULL
of	NULL
the	NULL
repeat	NULL
,	NULL
we	NULL
included	NULL
such	NULL
constructs	NULL
in	NULL
our	NULL
analysis	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

We	NULL
transfected	NULL
the	NULL
series	NULL
of	NULL
CAT	NULL
gene	NULL
constructs	NULL
into	NULL
NIH	NULL
3T3	NULL
fibroblasts	NULL
and	NULL
evaluated	NULL
CAT	NULL
activities	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Muta-	NULL
TABLE	NULL
1	NULL
.	NULL

E-boxes	NULL
contribute	NULL
to	NULL
the	NULL
MLV	NULL
transcriptional	NULL
activity	NULL
in	NULL
lymphoid	NULL
cell	NULL
lines	NULL
Normalized	NULL
CAT	NULL
activity	NULL
in	NULL
the	NULL
following	NULL
cell	NULL
line	NULL
``	NULL
:	NULL
Construct	NULL
NIH	NULL
3T3	NULL
Hela	NULL
WEHI7Z1	NULL
L691-6	NULL
J558L	NULL
Mpcl1	NULL
K562	NULL
pAKV6CAT	NULL
1.0	NULL
``	NULL
1.0	NULL
``	NULL
1.0	NULL
``	NULL
1.06	NULL
0	NULL
10	NULL
10°	NULL
10°	NULL
pE	NULL
(	NULL
c	NULL
)	NULL
CAT	NULL
1.0	NULL
0.8	NULL
0.5	NULL
0.4	NULL
0.6	NULL
0.7	NULL
0.6	NULL
pE	NULL
(	NULL
b	NULL
)	NULL
CAT	NULL
0.8	NULL
0.8	NULL
0.3	NULL
0.3	NULL
0.6	NULL
0.3	NULL
0.5	NULL
pE	NULL
(	NULL
a	NULL
)	NULL
CAT	NULL
1.2	NULL
1.1	NULL
0.3	NULL
0.3	NULL
0.9	NULL
0.6	NULL
0.6	NULL
pE	NULL
(	NULL
ab	NULL
)	NULL
CAT	NULL
1.1	NULL
0.8	NULL
0.2	NULL
0.1	NULL
0.4	NULL
0.3	NULL
0.5	NULL
pE	NULL
(	NULL
ac	NULL
)	NULL
CAT	NULL
1.0	NULL
0.9	NULL
0.2	NULL
0.1	NULL
0.6	NULL
0.6	NULL
0.6	NULL
pE	NULL
(	NULL
be	NULL
)	NULL
CAT	NULL
1.1	NULL
0.8	NULL
0.3	NULL
0.2	NULL
0.3	NULL
0.3	NULL
0.5	NULL
pE	NULL
(	NULL
abe	NULL
)	NULL
CAT	NULL
0.8	NULL
0.8	NULL
0.1	NULL
0.1	NULL
0.2	NULL
0.2	NULL
0.4	NULL
p1-9I9CAT	NULL
1.0	NULL
``	NULL
ND®	NULL
ND	NULL
1.06	NULL
0	NULL
100	NULL
-	NULL
10°	NULL
10°	NULL
plE	NULL
(	NULL
c	NULL
)	NULL
CAT	NULL
0.8	NULL
ND	NULL
ND	NULL
0.2	NULL
0.3	NULL
0.6	NULL
0.7	NULL
plE	NULL
(	NULL
b	NULL
)	NULL
CAT	NULL
0.8	NULL
ND	NULL
ND	NULL
0.2	NULL
0.1	NULL
0.3	NULL
0.7	NULL
plE	NULL
(	NULL
be	NULL
)	NULL
CAT	NULL
0.7	NULL
ND	NULL
ND	NULL
0.1	NULL
0.1	NULL
0.2	NULL
0.5	NULL
``	NULL
The	NULL
standard	NULL
deviation	NULL
from	NULL
the	NULL
mean	NULL
value	NULL
was	NULL
=20	NULL
%	NULL
except	NULL
for	NULL
K562	NULL
and	NULL
NIH	NULL
3T3	NULL
cells	NULL
,	NULL
for	NULL
which	NULL
the	NULL
standard	NULL
deviation	NULL
was	NULL
=25	NULL
%	NULL
.	NULL

*	NULL
Value	NULL
set	NULL
to	NULL
1.0	NULL
.	NULL

°	NULL
ND	NULL
,	NULL
not	NULL
done	NULL
.	NULL

VoL	NULL
.	NULL

70	NULL
,	NULL
1996	NULL
tions	NULL
in	NULL
either	NULL
E	NULL
,	NULL
,	NULL
,	NULL
(	NULL
A	NULL
)	NULL
or	NULL
E	NULL
,	NULL
,	NULL
,	NULL
(	NULL
B	NULL
)	NULL
or	NULL
the	NULL
double	NULL
mutation	NULL
resulted	NULL
in	NULL
no	NULL
significant	NULL
change	NULL
in	NULL
transcriptional	NULL
activity	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
promoter-proximal	NULL
E-box	NULL
Ea	NULL
,	NULL
&	NULL
(	NULL
C	NULL
)	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
.	NULL

Constructs	NULL
with	NULL
only	NULL
one	NULL
copy	NULL
of	NULL
the	NULL
99-bp	NULL
repeat	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
all	NULL
showed	NULL
a	NULL
small	NULL
reduction	NULL
in	NULL
transcriptional	NULL
activity	NULL
by	NULL
introduction	NULL
of	NULL
E-box	NULL
mutations	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
under	NULL
our	NULL
assay	NULL
conditions	NULL
,	NULL
the	NULL
Akv	NULL
MLV	NULL
E-boxes	NULL
seemed	NULL
to	NULL
contribute	NULL
only	NULL
weakly	NULL
to	NULL
the	NULL
high	NULL
Akv	NULL
MLV	NULL
transcriptional	NULL
activity	NULL
in	NULL
NIH	NULL
3T3	NULL
cells	NULL
.	NULL

We	NULL
notice	NULL
that	NULL
NIH	NULL
3T3	NULL
cells	NULL
lack	NULL
DNA-binding	NULL
bHLH	NULL
proteins	NULL
ALF1	NULL
and	NULL
ALF2	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

We	NULL
repeated	NULL
the	NULL
analysis	NULL
with	NULL
HeLa	NULL
cells	NULL
also	NULL
lacking	NULL
DNA-binding	NULL
class	NULL
A	NULL
bHLH	NULL
proteins	NULL
.	NULL

As	NULL
observed	NULL
in	NULL
NIH	NULL
3T3	NULL
cells	NULL
,	NULL
the	NULL
mutations	NULL
of	NULL
Aky	NULL
MLV	NULL
E-boxes	NULL
resulted	NULL
in	NULL
only	NULL
a	NULL
reduced	NULL
transcription	NULL
relative	NULL
to	NULL
the	NULL
levels	NULL
of	NULL
the	NULL
parental	NULL
construct	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
HeLa	NULL
cells	NULL
,	NULL
as	NULL
in	NULL
NIH	NULL
3T3	NULL
cells	NULL
,	NULL
the	NULL
MLV	NULL
E-boxes	NULL
contributed	NULL
only	NULL
slightly	NULL
to	NULL
MLV	NULL
transcription	NULL
.	NULL

E-boxes	NULL
contribute	NULL
to	NULL
Aky	NULL
MLV	NULL
transcriptional	NULL
activity	NULL
in	NULL
T-	NULL
and	NULL
B-cell	NULL
lines	NULL
.	NULL

In	NULL
previous	NULL
studies	NULL
,	NULL
E-boxes	NULL
were	NULL
found	NULL
to	NULL
contribute	NULL
to	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
lymphoid	NULL
cell-ex-pressed	NULL
genes	NULL
,	NULL
such	NULL
as	NULL
the	NULL
immunoglobulin	NULL
and	NULL
CD4	NULL
genes	NULL
(	NULL
22	NULL
,	NULL
38	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
if	NULL
intact	NULL
E-boxes	NULL
contributed	NULL
to	NULL
the	NULL
Akv	NULL
MLV	NULL
transcriptional	NULL
activity	NULL
in	NULL
lymphoid	NULL
cells	NULL
relevant	NULL
for	NULL
MLV	NULL
oncogenesis	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
panel	NULL
of	NULL
Aky	NULL
MLV	NULL
mutant	NULL
constructs	NULL
in	NULL
the	NULL
L691-6	NULL
and	NULL
WEHI7.1	NULL
T-cell	NULL
lines	NULL
.	NULL

The	NULL
pE	NULL
(	NULL
c	NULL
)	NULL
CAT	NULL
construct	NULL
had	NULL
a	NULL
twofold-lower	NULL
transcriptional	NULL
activity	NULL
than	NULL
the	NULL
parental	NULL
construct	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Mutation	NULL
of	NULL
either	NULL
E	NULL
,	NULL
,	NULL
,	NULL
(	NULL
A	NULL
)	NULL
or	NULL
E	NULL
,	NULL
,	NULL
(	NULL
B	NULL
)	NULL
decreased	NULL
the	NULL
transcriptional	NULL
activity	NULL
approximately	NULL
fourfold	NULL
,	NULL
whereas	NULL
the	NULL
pE	NULL
(	NULL
ab	NULL
)	NULL
CAT	NULL
construct	NULL
had	NULL
a	NULL
5-	NULL
to	NULL
10-fold-decreased	NULL
activity	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
for	NULL
Aky	NULL
MLV	NULL
,	NULL
E-boxes	NULL
are	NULL
essential	NULL
for	NULL
transcriptional	NULL
activity	NULL
in	NULL
T-cell	NULL
lines	NULL
.	NULL

Removal	NULL
of	NULL
one	NULL
copy	NULL
of	NULL
the	NULL
repeat	NULL
did	NULL
not	NULL
affect	NULL
Akvy	NULL
MLV	NULL
transcriptional	NULL
activity	NULL
pronouncedly	NULL
in	NULL
L691-6	NULL
cells	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Introduction	NULL
of	NULL
either	NULL
single	NULL
or	NULL
double	NULL
E-box	NULL
mutations	NULL
reduced	NULL
the	NULL
transcriptional	NULL
activity	NULL
equivalently	NULL
to	NULL
the	NULL
decrease	NULL
caused	NULL
by	NULL
the	NULL
same	NULL
mutations	NULL
in	NULL
the	NULL
parental	NULL
construct	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
a	NULL
T-cell	NULL
line	NULL
,	NULL
the	NULL
absence	NULL
of	NULL
one	NULL
copy	NULL
of	NULL
the	NULL
Aky	NULL
MLV	NULL
enhancer	NULL
repeat	NULL
did	NULL
not	NULL
enhance	NULL
the	NULL
importance	NULL
of	NULL
the	NULL
remaining	NULL
E-box	NULL
motifs	NULL
.	NULL

The	NULL
greater	NULL
importance	NULL
of	NULL
the	NULL
E	NULL
,	NULL
,	NULL
,	NULL
(	NULL
A	NULL
)	NULL
and	NULL
E	NULL
,	NULL
,	NULL
_	NULL
(	NULL
B	NULL
)	NULL
motifs	NULL
in	NULL
T-cell	NULL
lines	NULL
than	NULL
in	NULL
fibroblasts	NULL
and	NULL
HeLa	NULL
cells	NULL
correlates	NULL
with	NULL
the	NULL
appearance	NULL
of	NULL
the	NULL
class	NULL
A	NULL
bHLH	NULL
complex	NULL
NFC	NULL
,	NULL
,	NULL
.1	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

We	NULL
also	NULL
tested	NULL
the	NULL
importance	NULL
of	NULL
Akvy	NULL
MLV	NULL
E-boxes	NULL
for	NULL
transcriptional	NULL
activity	NULL
in	NULL
two	NULL
B-cell	NULL
lines	NULL
.	NULL

In	NULL
the	NULL
B-cell	NULL
lines	NULL
,	NULL
the	NULL
pE	NULL
(	NULL
c	NULL
)	NULL
CAT	NULL
construct	NULL
had	NULL
a	NULL
lower	NULL
transcriptional	NULL
activity	NULL
than	NULL
the	NULL
wild-type	NULL
construct	NULL
,	NULL
as	NULL
observed	NULL
in	NULL
T-cell	NULL
lines	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

In	NULL
both	NULL
cell	NULL
lines	NULL
,	NULL
the	NULL
pE	NULL
(	NULL
b	NULL
)	NULL
CAT	NULL
construct	NULL
had	NULL
a	NULL
decreased	NULL
transcriptional	NULL
activity	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
the	NULL
pE	NULL
(	NULL
a	NULL
)	NULL
CAT	NULL
construct	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
promoter-proximal	NULL
E	NULL
,	NULL
,	NULL
_	NULL
(	NULL
B	NULL
)	NULL
was	NULL
more	NULL
important	NULL
for	NULL
the	NULL
enhancer	NULL
function	NULL
than	NULL
the	NULL
distal	NULL
E	NULL
,	NULL
,	NULL
,	NULL
(	NULL
A	NULL
)	NULL
motif	NULL
.	NULL

In	NULL
agreement	NULL
,	NULL
the	NULL
E	NULL
(	NULL
b	NULL
)	NULL
mutation	NULL
and	NULL
the	NULL
double	NULL
mutation	NULL
E	NULL
(	NULL
ab	NULL
)	NULL
had	NULL
equivalent	NULL
activities	NULL
,	NULL
and	NULL
pE	NULL
(	NULL
be	NULL
)	NULL
CAT	NULL
had	NULL
lower	NULL
activity	NULL
than	NULL
pE	NULL
(	NULL
ac	NULL
)	NULL
CAT	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggested	NULL
that	NULL
in	NULL
B-cell	NULL
lines	NULL
the	NULL
E	NULL
,	NULL
,	NULL
,	NULL
(	NULL
B	NULL
)	NULL
motif	NULL
was	NULL
more	NULL
important	NULL
than	NULL
E	NULL
,	NULL
,	NULL
,	NULL
(	NULL
A	NULL
)	NULL
in	NULL
control	NULL
of	NULL
Aky	NULL
MLV	NULL
transcription	NULL
.	NULL

The	NULL
construct	NULL
with	NULL
the	NULL
triple	NULL
mutation	NULL
had	NULL
a	NULL
fivefold-reduced	NULL
transcriptional	NULL
activity	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
the	NULL
parental	NULL
construct	NULL
,	NULL
showing	NULL
the	NULL
major	NULL
importance	NULL
for	NULL
Akv	NULL
MLV	NULL
E-boxes	NULL
in	NULL
mediating	NULL
transcription	NULL
in	NULL
B-cell	NULL
lines	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Removal	NULL
of	NULL
one	NULL
copy	NULL
of	NULL
the	NULL
enhancer	NULL
repeat	NULL
decrease	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
Akvy	NULL
MLV	NULL
threefold	NULL
in	NULL
the	NULL
B-cell	NULL
lines	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Introduction	NULL
of	NULL
a	NULL
mutation	NULL
in	NULL
E	NULL
,	NULL
,	NULL
\	NULL
(	NULL
B	NULL
)	NULL
decreased	NULL
transcriptional	NULL
activity	NULL
pronouncedly	NULL
in	NULL
the	NULL
background	NULL
of	NULL
p1-99CAT	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
mutations	NULL
E	NULL
(	NULL
c	NULL
)	NULL
and	NULL
E	NULL
(	NULL
be	NULL
)	NULL
decreased	NULL
the	NULL
transcriptional	NULL
activity	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
removal	NULL
of	NULL
one	NULL
copy	NULL
of	NULL
the	NULL
99-bp	NULL
repeat	NULL
increased	NULL
the	NULL
importance	NULL
for	NULL
bHLH	NULL
PROTEINS	NULL
REGULATE	NULL
MLV	NULL
TRANSCRIPTION	NULL
5897	NULL
intact	NULL
E-boxes	NULL
in	NULL
B-cell	NULL
lines	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
in	NULL
T-	NULL
and	NULL
B-cell	NULL
lines	NULL
,	NULL
E-boxes	NULL
and	NULL
in	NULL
particular	NULL
enhancer	NULL
E	NULL
,	NULL
,	NULL
,	NULL
E-boxes	NULL
have	NULL
major	NULL
importance	NULL
for	NULL
proper	NULL
Aky	NULL
MLV	NULL
transcription	NULL
.	NULL

In	NULL
T-cell	NULL
lines	NULL
,	NULL
E	NULL
,	NULL
,	NULL
,	NULL
(	NULL
A	NULL
)	NULL
and	NULL
E	NULL
,	NULL
,	NULL
_	NULL
(	NULL
B	NULL
)	NULL
might	NULL
be	NULL
of	NULL
equivalent	NULL
importance	NULL
,	NULL
whereas	NULL
E	NULL
,	NULL
,	NULL
,	NULL
(	NULL
B	NULL
)	NULL
might	NULL
be	NULL
more	NULL
important	NULL
than	NULL
E	NULL
,	NULL
,	NULL
,	NULL
(	NULL
A	NULL
)	NULL
in	NULL
B-cell	NULL
lines	NULL
.	NULL

In	NULL
the	NULL
K562	NULL
erythroleukemia	NULL
cell	NULL
line	NULL
,	NULL
class	NULL
A	NULL
bHLH	NULL
proteins	NULL
exist	NULL
in	NULL
heterodimeric	NULL
complexes	NULL
with	NULL
the	NULL
class	NULL
B	NULL
bHLH	NULL
oncoprotein	NULL
TAL1	NULL
(	NULL
14	NULL
,	NULL
30	NULL
)	NULL
.	NULL

In	NULL
K562	NULL
cells	NULL
,	NULL
a	NULL
twofold	NULL
reduction	NULL
in	NULL
transcription	NULL
resulting	NULL
from	NULL
the	NULL
E	NULL
,	NULL
,	NULL
,	NULL
mutations	NULL
E	NULL
(	NULL
a	NULL
)	NULL
,	NULL
E	NULL
(	NULL
b	NULL
)	NULL
,	NULL
and	NULL
E	NULL
(	NULL
ab	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
Ea	NULL
,	NULL
,	NULL
mutation	NULL
E	NULL
(	NULL
c	NULL
)	NULL
,	NULL
was	NULL
observed	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Removal	NULL
of	NULL
one	NULL
copy	NULL
of	NULL
the	NULL
Aky	NULL
MLV	NULL
enhancer	NULL
repeat	NULL
decreased	NULL
the	NULL
transcriptional	NULL
activity	NULL
in	NULL
K562	NULL
cells	NULL
twofold	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
the	NULL
parental-type	NULL
enhancer	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

By	NULL
further	NULL
introduction	NULL
of	NULL
mutations	NULL
in	NULL
the	NULL
E-boxes	NULL
,	NULL
we	NULL
observed	NULL
a	NULL
decrease	NULL
in	NULL
activity	NULL
smaller	NULL
than	NULL
the	NULL
decrease	NULL
observed	NULL
for	NULL
E-box	NULL
mutations	NULL
in	NULL
the	NULL
parental-type	NULL
construct	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
in	NULL
T-cell	NULL
lines	NULL
and	NULL
an	NULL
erythroleukemia	NULL
cell	NULL
line	NULL
,	NULL
E-box-binding	NULL
protein	NULL
complexes	NULL
transactivate	NULL
equivalently	NULL
through	NULL
both	NULL
enhancer	NULL
E	NULL
,	NULL
,	NULL
,	NULL
E-boxes	NULL
,	NULL
and	NULL
in	NULL
B-cell	NULL
lines	NULL
,	NULL
protein	NULL
complexes	NULL
transactivate	NULL
preferentially	NULL
through	NULL
the	NULL
most	NULL
promoter-proximal	NULL
enhancer	NULL
E-box	NULL
,	NULL
E	NULL
,	NULL
,	NULL
,	NULL
(	NULL
B	NULL
)	NULL
.	NULL

ALF1	NULL
and	NULL
E2A	NULL
transactivations	NULL
have	NULL
different	NULL
enhancer	NULL
E-box	NULL
constraints	NULL
.	NULL

Since	NULL
bHLH	NULL
proteins	NULL
were	NULL
found	NULL
to	NULL
interact	NULL
solely	NULL
with	NULL
the	NULL
motifs	NULL
E	NULL
,	NULL
,	NULL
\	NULL
(	NULL
A	NULL
)	NULL
and	NULL
E	NULL
,	NULL
,	NULL
\	NULL
(	NULL
B	NULL
)	NULL
and	NULL
since	NULL
distinct	NULL
E-boxes	NULL
contribute	NULL
differently	NULL
to	NULL
Akv	NULL
MLV	NULL
transcriptional	NULL
activity	NULL
in	NULL
lymphocytes	NULL
,	NULL
we	NULL
wanted	NULL
to	NULL
examine	NULL
the	NULL
activator	NULL
capacity	NULL
of	NULL
class	NULL
A	NULL
bHLH	NULL
proteins	NULL
.	NULL

We	NULL
cotransfected	NULL
the	NULL
different	NULL
Aky	NULL
MLV-based	NULL
CAT	NULL
constructs	NULL
into	NULL
NIH	NULL
3T3	NULL
cells	NULL
with	NULL
the	NULL
ALF1	NULL
expression	NULL
vector	NULL
and	NULL
evaluated	NULL
CAT	NULL
activities	NULL
for	NULL
the	NULL
examination	NULL
of	NULL
the	NULL
putative	NULL
activator	NULL
function	NULL
of	NULL
ALF1	NULL
.	NULL

As	NULL
previously	NULL
observed	NULL
,	NULL
ALF1	NULL
transactivates	NULL
the	NULL
wild-type	NULL
pAKV6CAT	NULL
construct	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
and	NULL
4	NULL
)	NULL
(	NULL
32	NULL
)	NULL
.	NULL

The	NULL
pE	NULL
(	NULL
c	NULL
)	NULL
CAT	NULL
construct	NULL
was	NULL
transactivated	NULL
by	NULL
ALF1	NULL
,	NULL
whereas	NULL
the	NULL
pE	NULL
(	NULL
ab	NULL
)	NULL
CAT	NULL
and	NULL
pE	NULL
(	NULL
abe	NULL
)	NULL
CAT	NULL
constructs	NULL
did	NULL
not	NULL
respond	NULL
positively	NULL
to	NULL
ALF1	NULL
overexpression	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
enhancer	NULL
E-boxes	NULL
are	NULL
necessary	NULL
for	NULL
ALFI1	NULL
function	NULL
,	NULL
which	NULL
is	NULL
in	NULL
accordance	NULL
with	NULL
the	NULL
observations	NULL
that	NULL
enhancer-localized	NULL
E	NULL
,	NULL
,	NULL
,	NULL
motifs	NULL
are	NULL
binding	NULL
sites	NULL
for	NULL
ALF1	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
(	NULL
32	NULL
)	NULL
.	NULL

The	NULL
constructs	NULL
pE	NULL
(	NULL
a	NULL
)	NULL
CAT	NULL
and	NULL
pE	NULL
(	NULL
b	NULL
)	NULL
CAT	NULL
responded	NULL
identically	NULL
to	NULL
transactivation	NULL
by	NULL
ALF1	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
single	NULL
enhancer	NULL
E-box	NULL
is	NULL
sufficient	NULL
for	NULL
mediating	NULL
a	NULL
positive	NULL
ALF1	NULL
transcriptional	NULL
signal	NULL
,	NULL
similar	NULL
to	NULL
the	NULL
observations	NULL
for	NULL
T-cell	NULL
lines	NULL
with	NULL
DNA-binding	NULL
ALF	NULL
]	NULL
subunits	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
examined	NULL
CAT	NULL
constructs	NULL
for	NULL
transcriptional	NULL
transactivation	NULL
mediated	NULL
by	NULL
the	NULL
£24	NULL
gene-en-coded	NULL
protein	NULL
,	NULL
E2-5	NULL
.	NULL

Like	NULL
ALF1	NULL
,	NULL
E2-5	NULL
required	NULL
intact	NULL
E	NULL
,	NULL
,	NULL
,	NULL
motifs	NULL
for	NULL
mediating	NULL
transcriptional	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
pE	NULL
(	NULL
a	NULL
)	NULL
CAT	NULL
construct	NULL
was	NULL
transactivated	NULL
,	NULL
while	NULL
the	NULL
pE	NULL
(	NULL
b	NULL
)	NULL
CAT	NULL
construct	NULL
was	NULL
not	NULL
significantly	NULL
activated	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
ALF1	NULL
and	NULL
E2A	NULL
proteins	NULL
have	NULL
different	NULL
E-box	NULL
constraints	NULL
for	NULL
mediating	NULL
transcriptional	NULL
activation	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
the	NULL
E	NULL
,	NULL
,	NULL
,	NULL
(	NULL
B	NULL
)	NULL
motif	NULL
in	NULL
EZ2A-mediated	NULL
transcriptional	NULL
activation	NULL
parallels	NULL
the	NULL
importance	NULL
of	NULL
the	NULL
intact	NULL
motif	NULL
for	NULL
mediating	NULL
transcriptional	NULL
activity	NULL
in	NULL
B-cell	NULL
lines	NULL
,	NULL
a	NULL
cell	NULL
type	NULL
in	NULL
which	NULL
EZA	NULL
subunit-including	NULL
complexes	NULL
bind	NULL
to	NULL
the	NULL
motif	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

In	NULL
constructs	NULL
in	NULL
which	NULL
one	NULL
copy	NULL
of	NULL
the	NULL
enhancer	NULL
repeat	NULL
is	NULL
removed	NULL
,	NULL
EZA	NULL
protein	NULL
E2-5	NULL
and	NULL
ALF1	NULL
transactivated	NULL
transcription	NULL
equally	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

The	NULL
different	NULL
E-box	NULL
requirements	NULL
for	NULL
transcriptional	NULL
activation	NULL
mediated	NULL
by	NULL
EZ2A	NULL
protein	NULL
E2-5	NULL
and	NULL
ALF1	NULL
suggest	NULL
that	NULL
these	NULL
two	NULL
very	NULL
homologous	NULL
proteins	NULL
somehow	NULL
may	NULL
contact	NULL
the	NULL
transcriptional	NULL
machinery	NULL
formed	NULL
on	NULL
the	NULL
MLV	NULL
promoter-enhancer	NULL
differently	NULL
.	NULL

Id1	NULL
out-titrates	NULL
bHLH	NULL
protein-mediated	NULL
MLV	NULL
transactivation	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
effect	NULL
of	NULL
Id1	NULL
on	NULL
MLV	NULL
E-box	NULL
DNA-bind-	NULL
5898	NULL
A	NULL
300	NULL
NIELSEN	NULL
ET	NULL
AL	NULL
.	NULL

-ALFM1	NULL
_	NULL
[	NULL
]	NULL
+ALpm	NULL
-	NULL
&	NULL
ps	NULL
ro	NULL
on	NULL
-l	NULL
Un	NULL
o	NULL
o	NULL
o	NULL
1	NULL
|	NULL
I	NULL
Normalized	NULL
CAT	NULL
activity	NULL
3	NULL
I	NULL
th	NULL
G	NULL
1	NULL
hues	NULL
ERSA	NULL
E	NULL
(	NULL
c	NULL
)	NULL
E	NULL
(	NULL
a	NULL
)	NULL
|	NULL
E	NULL
(	NULL
ac	NULL
)	NULL
E	NULL
(	NULL
ab	NULL
)	NULL
E	NULL
(	NULL
abc	NULL
)	NULL
E	NULL
(	NULL
be	NULL
)	NULL
1-99	NULL
1E	NULL
(	NULL
b	NULL
)	NULL
|	NULL
1E	NULL
(	NULL
be	NULL
)	NULL
1E	NULL
(	NULL
c	NULL
)	NULL
300	NULL
-	NULL
E2-5	NULL
[	NULL
]	NULL
+E2-5	NULL
250	NULL
no	NULL
o	NULL
o	NULL
1	NULL
Normalized	NULL
CAT	NULL
activity	NULL
T__	NULL
on	NULL
&	NULL
1	NULL
o	NULL
|	NULL
1	NULL
C4	NULL
Akyv	NULL
E	NULL
(	NULL
b	NULL
)	NULL
E	NULL
(	NULL
a	NULL
)	NULL
E	NULL
(	NULL
ab	NULL
)	NULL
1-99	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

ALF1	NULL
and	NULL
E2A	NULL
proteins	NULL
have	NULL
different	NULL
constraints	NULL
for	NULL
E-box-medi-ated	NULL
transcriptional	NULL
activation	NULL
.	NULL

The	NULL
CAT	NULL
reporter	NULL
constructs	NULL
(	NULL
2	NULL
pg	NULL
)	NULL
depicted	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
were	NULL
cotransfected	NULL
in	NULL
NIH	NULL
3T3	NULL
cells	NULL
(	NULL
5	NULL
x	NULL
10°	NULL
)	NULL
with	NULL
empty	NULL
expression	NULL
vectors	NULL
and	NULL
vectors	NULL
expressing	NULL
either	NULL
ALF1	NULL
(	NULL
A	NULL
)	NULL
or	NULL
E2-5	NULL
(	NULL
B	NULL
)	NULL
.	NULL

In	NULL
all	NULL
cases	NULL
,	NULL
the	NULL
total	NULL
amount	NULL
of	NULL
expression	NULL
vector	NULL
was	NULL
2	NULL
ug	NULL
per	NULL
transfection	NULL
.	NULL

Five	NULL
micrograms	NULL
of	NULL
pCH110	NULL
was	NULL
included	NULL
as	NULL
an	NULL
internal	NULL
standard	NULL
expressing	NULL
B-galactosidase	NULL
from	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
promoter	NULL
.	NULL

CAT	NULL
activities	NULL
normalized	NULL
for	NULL
B-galactosidase	NULL
activities	NULL
were	NULL
estimated	NULL
and	NULL
visualized	NULL
by	NULL
setting	NULL
the	NULL
value	NULL
for	NULL
reporter	NULL
constructs	NULL
without	NULL
bHLH	NULL
overexpression	NULL
to	NULL
100	NULL
.	NULL

The	NULL
standard	NULL
deviation	NULL
from	NULL
the	NULL
mean	NULL
values	NULL
was	NULL
<	NULL
20	NULL
%	NULL
.	NULL

1E	NULL
(	NULL
b	NULL
)	NULL
ing	NULL
bHLH	NULL
proteins	NULL
in	NULL
vitro	NULL
,	NULL
we	NULL
did	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
.	NULL

An	NULL
oligonucleotide	NULL
including	NULL
the	NULL
E	NULL
,	NULL
,	NULL
,	NULL
motif	NULL
was	NULL
used	NULL
as	NULL
a	NULL
DNA	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

Purified	NULL
ALF1sze	NULL
»	NULL
_	NULL
706	NULL
resulted	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
a	NULL
doublet	NULL
of	NULL
retarded	NULL
bands	NULL
constituting	NULL
DNA-binding	NULL
ALF1	NULL
oligomers	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
GST	NULL
-Id1	NULL
to	NULL
ALF1sg	NULL
;	NULL
794	NULL
resulted	NULL
in	NULL
a	NULL
nearly	NULL
100	NULL
%	NULL
reduction	NULL
of	NULL
ALF1	NULL
DNA	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
Id1	NULL
functions	NULL
in	NULL
vitro	NULL
as	NULL
a	NULL
repressor	NULL
of	NULL
ALF1	NULL
DNA-binding	NULL
activity	NULL
,	NULL
as	NULL
observed	NULL
for	NULL
other	NULL
class	NULL
A	NULL
bHLH	NULL
proteins	NULL
.	NULL

We	NULL
examined	NULL
the	NULL
repressive	NULL
effect	NULL
of	NULL
Id1	NULL
in	NULL
vivo	NULL
on	NULL
MLV	NULL
transcription	NULL
in	NULL
NIH	NULL
3T3	NULL
cells	NULL
,	NULL
using	NULL
pAKV6CAT	NULL
or	NULL
pSL3-3CAT	NULL
as	NULL
a	NULL
reporter	NULL
construct	NULL
.	NULL

Ectopic	NULL
expression	NULL
of	NULL
Id1	NULL
did	NULL
not	NULL
influence	NULL
the	NULL
transcription	NULL
of	NULL
pAKV6CAT	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
ALF1-mediated	NULL
transcriptional	NULL
activation	NULL
was	NULL
significantly	NULL
reduced	NULL
when	NULL
we	NULL
coexpressed	NULL
Id1	NULL
with	NULL
ALF1	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

The	NULL
repressive	NULL
effect	NULL
of	NULL
Id1	NULL
on	NULL
ALFI1	NULL
transactivation	NULL
was	NULL
ob	NULL
J.	NULL
ViRoL	NULL
.	NULL

A	NULL
GST	NULL
To	NULL
m	NULL
#	NULL
-	NULL
GST-ALA1	NULL
-	NULL
+	NULL
+	NULL
-	NULL
+	NULL
GST-4d1	NULL
c	NULL
c	NULL
c	NULL
q	NULL
4	NULL
<	NULL
-	NULL
tth	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
pAKVéCAT	NULL
200	NULL
€	NULL
i	NULL
150	NULL
E100	NULL
B	NULL
§	NULL
s-~	NULL
0	NULL
T	NULL
T	NULL
``	NULL
T	NULL
--	NULL
I	NULL
Basal	NULL
+	NULL
ALF1	NULL
+	NULL
1d1	NULL
+	NULL
ALF1	NULL
,	NULL
+	NULL
1d1	NULL
C	NULL
pSL3-3CAT	NULL
Normalized	NULL
CAT	NULL
activity	NULL
+	NULL
ALF1	NULL
+	NULL
Id1	NULL
Basal	NULL
+	NULL
ALF1	NULL
,	NULL
+	NULL
Id1	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Id1	NULL
represses	NULL
ALF1-HEB	NULL
activity	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Id1	NULL
inhibits	NULL
ALF	NULL
]	NULL
DNA	NULL
binding	NULL
in	NULL
vitro	NULL
.	NULL

An	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
was	NULL
done	NULL
with	NULL
P-labeled	NULL
double-stranded	NULL
E	NULL
,	NULL
,	NULL
,	NULL
oligonucleotide	NULL
and	NULL
the	NULL
purified	NULL
proteins	NULL
GST-ALF1se	NULL
>	NULL
704	NULL
,	NULL
GST	NULL
,	NULL
and	NULL
GST-Id1	NULL
as	NULL
indicated	NULL
.	NULL

(	NULL
B	NULL
and	NULL
C	NULL
)	NULL
Id1	NULL
inhibits	NULL
ALF1	NULL
activity	NULL
in	NULL
vivo	NULL
.	NULL

In	NULL
NIH	NULL
3T3	NULL
cells	NULL
(	NULL
5	NULL
X	NULL
10°	NULL
)	NULL
,	NULL
pAKV6CAT	NULL
(	NULL
2	NULL
ug	NULL
)	NULL
(	NULL
B	NULL
)	NULL
or	NULL
pSL3-3CAT	NULL
(	NULL
2	NULL
ug	NULL
)	NULL
(	NULL
C	NULL
)	NULL
was	NULL
cotransfected	NULL
with	NULL
empty	NULL
parental	NULL
expression	NULL
vectors	NULL
and	NULL
expression	NULL
vector	NULL
Id1	NULL
or	NULL
ALF1	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

In	NULL
all	NULL
cases	NULL
,	NULL
a	NULL
total	NULL
of	NULL
2	NULL
ug	NULL
of	NULL
expression	NULL
vector	NULL
was	NULL
used	NULL
per	NULL
transfection	NULL
.	NULL

Five	NULL
micrograms	NULL
of	NULL
pCHI110	NULL
was	NULL
included	NULL
as	NULL
an	NULL
internal	NULL
standard	NULL
expressing	NULL
B-galactosidase	NULL
from	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
promoter	NULL
.	NULL

B-Galactosidase-normalized	NULL
CAT	NULL
activities	NULL
were	NULL
estimated	NULL
by	NULL
using	NULL
the	NULL
parental	NULL
expression	NULL
vectors	NULL
arbitrarily	NULL
set	NULL
to	NULL
100	NULL
.	NULL

The	NULL
standard	NULL
deviations	NULL
from	NULL
the	NULL
mean	NULL
values	NULL
were	NULL
=15	NULL
%	NULL
in	NULL
panel	NULL
B	NULL
and	NULL
=20	NULL
%	NULL
in	NULL
panel	NULL
C.	NULL
Vor	NULL
.	NULL

70	NULL
,	NULL
1996	NULL
bHLH	NULL
PROTEINS	NULL
REGULATE	NULL
MLV	NULL
TRANSCRIPTION	NULL
5899	NULL
TABLE	NULL
2	NULL
.	NULL

E.	NULL
,	NULL
.-directed	NULL
MLV	NULL
transcription	NULL
is	NULL
repressed	NULL
by	NULL
Id1	NULL
in	NULL
lymphoid	NULL
cell	NULL
lines	NULL
Normalized	NULL
CAT	NULL
activity	NULL
``	NULL
Construct	NULL
L691-6	NULL
``	NULL
Mpe11	NULL
``	NULL
Mpel1°	NULL
J558L	NULL
Without	NULL
Id1	NULL
With	NULL
Id1	NULL
Without	NULL
Id1	NULL
With	NULL
Id1	NULL
Without	NULL
Id1	NULL
With	NULL
Id1	NULL
Without	NULL
Id1	NULL
With	NULL
Id1	NULL
pAKV6CAT	NULL
1.0¢	NULL
0.5	NULL
1.0¢	NULL
1.0	NULL
1.0¢	NULL
0.6	NULL
1.0	NULL
``	NULL
1.1	NULL
pE	NULL
(	NULL
ab	NULL
)	NULL
CAT	NULL
1.0	NULL
``	NULL
1.0	NULL
ND	NULL
ND	NULL
ND	NULL
ND	NULL
1.0	NULL
``	NULL
1.1	NULL
pSL3-3CAT	NULL
1.0¢	NULL
0.5	NULL
1.0¢	NULL
0.4	NULL
1.0¢	NULL
0.2	NULL
1.0	NULL
``	NULL
0.5	NULL
``	NULL
The	NULL
standard	NULL
deviation	NULL
from	NULL
the	NULL
mean	NULL
value	NULL
was	NULL
=20	NULL
%	NULL
.	NULL

®	NULL
Five	NULL
micrograms	NULL
of	NULL
CAT	NULL
reporter	NULL
construct	NULL
was	NULL
included	NULL
in	NULL
each	NULL
transfection	NULL
.	NULL

©	NULL
One	NULL
microgram	NULL
of	NULL
CAT	NULL
reporter	NULL
construct	NULL
was	NULL
included	NULL
in	NULL
each	NULL
transfection	NULL
.	NULL

@	NULL
Value	NULL
set	NULL
to	NULL
1.0	NULL
.	NULL

®	NULL
ND	NULL
,	NULL
not	NULL
done	NULL
.	NULL

served	NULL
with	NULL
the	NULL
pSL3-3CAT	NULL
construct	NULL
as	NULL
well	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
Id1	NULL
may	NULL
function	NULL
as	NULL
a	NULL
repressor	NULL
of	NULL
ALF1-mediated	NULL
MLV	NULL
transcription	NULL
in	NULL
vivo	NULL
.	NULL

Id1	NULL
represses	NULL
MLV	NULL
transcription	NULL
in	NULL
lymphoid	NULL
cell	NULL
lines	NULL
.	NULL

The	NULL
bHLH	NULL
protein	NULL
complexes	NULL
from	NULL
lymphoid	NULL
cell	NULL
nuclear	NULL
extracts	NULL
that	NULL
were	NULL
found	NULL
to	NULL
interact	NULL
with	NULL
the	NULL
E	NULL
,	NULL
,	NULL
,	NULL
motifs	NULL
are	NULL
targets	NULL
for	NULL
dissociation	NULL
by	NULL
Id	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

It	NULL
deserves	NULL
notice	NULL
that	NULL
covalent	NULL
linking	NULL
between	NULL
the	NULL
protein	NULL
members	NULL
in	NULL
class	NULL
A	NULL
bHLH	NULL
homodimers	NULL
has	NULL
been	NULL
identified	NULL
(	NULL
3	NULL
)	NULL
and	NULL
that	NULL
Id	NULL
proteins	NULL
dissociate	NULL
TAL1-E2A	NULL
heterodimers	NULL
inefficiently	NULL
(	NULL
16	NULL
,	NULL
30	NULL
)	NULL
.	NULL

In	NULL
the	NULL
L691-6	NULL
T-cell	NULL
line	NULL
,	NULL
ectopic	NULL
expression	NULL
of	NULL
Id1	NULL
resulted	NULL
in	NULL
a	NULL
50	NULL
%	NULL
reduction	NULL
in	NULL
the	NULL
transcriptional	NULL
activity	NULL
from	NULL
pAKV6	NULL
CAT	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

Use	NULL
of	NULL
the	NULL
pE	NULL
(	NULL
ab	NULL
)	NULL
CAT	NULL
construct	NULL
showed	NULL
that	NULL
repression	NULL
by	NULL
Id1	NULL
required	NULL
intact	NULL
E	NULL
,	NULL
,	NULL
,	NULL
motifs	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

That	NULL
ectopic	NULL
Id1	NULL
in	NULL
a	NULL
T-cell	NULL
line	NULL
can	NULL
function	NULL
as	NULL
a	NULL
transcriptional	NULL
regulator	NULL
by	NULL
mediating	NULL
MLV	NULL
transcriptional	NULL
repression	NULL
verifies	NULL
that	NULL
class	NULL
A	NULL
bHLH	NULL
proteins	NULL
are	NULL
important	NULL
Akv	NULL
MLV	NULL
transcription	NULL
factors	NULL
in	NULL
T-cell	NULL
lines	NULL
.	NULL

Use	NULL
of	NULL
the	NULL
pSL3-3CAT	NULL
construct	NULL
as	NULL
a	NULL
reporter	NULL
showed	NULL
that	NULL
Id1	NULL
also	NULL
has	NULL
the	NULL
capacity	NULL
to	NULL
regulate	NULL
SL3-3	NULL
MLV	NULL
's	NULL
transcriptional	NULL
level	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
existence	NULL
of	NULL
identical	NULL
E-boxes	NULL
in	NULL
Akv	NULL
and	NULL
SL3-3	NULL
MLV	NULL
enhancers	NULL
resulted	NULL
in	NULL
the	NULL
same	NULL
response	NULL
to	NULL
Id1	NULL
protein	NULL
in	NULL
a	NULL
T-cell	NULL
line	NULL
.	NULL

In	NULL
B-cell	NULL
lines	NULL
(	NULL
Mpc11	NULL
and	NULL
J558L	NULL
)	NULL
,	NULL
ectopic	NULL
expression	NULL
of	NULL
Id1	NULL
again	NULL
resulted	NULL
in	NULL
a	NULL
roughly	NULL
50	NULL
%	NULL
reduction	NULL
of	NULL
transcription	NULL
from	NULL
the	NULL
pSL3-3CAT	NULL
construct	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

pAKV6CAT	NULL
was	NULL
not	NULL
repressed	NULL
by	NULL
ectopic	NULL
expression	NULL
of	NULL
Id1	NULL
in	NULL
the	NULL
B-cell	NULL
lines	NULL
under	NULL
the	NULL
experimental	NULL
conditions	NULL
used	NULL
for	NULL
the	NULL
T-cell	NULL
line	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
use	NULL
of	NULL
5	NULL
pg	NULL
of	NULL
CAT	NULL
reporter	NULL
construct	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

However	NULL
,	NULL
by	NULL
using	NULL
a	NULL
smaller	NULL
amount	NULL
of	NULL
Aky	NULL
MLV	NULL
reporter	NULL
construct	NULL
(	NULL
1	NULL
ug	NULL
)	NULL
,	NULL
a	NULL
repression	NULL
by	NULL
Id1	NULL
was	NULL
detectable	NULL
,	NULL
confirming	NULL
that	NULL
Akvy	NULL
MLV	NULL
was	NULL
under	NULL
transcriptional	NULL
regulation	NULL
by	NULL
class	NULL
A	NULL
bHLH	NULL
proteins	NULL
in	NULL
B-cell	NULL
lines	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
although	NULL
Akvy	NULL
MLV	NULL
and	NULL
SL3-3	NULL
MLV	NULL
carry	NULL
almost	NULL
the	NULL
same	NULL
set	NULL
of	NULL
E-box	NULL
sequences	NULL
,	NULL
they	NULL
did	NULL
not	NULL
respond	NULL
exactly	NULL
alike	NULL
to	NULL
ectopic	NULL
Id1	NULL
in	NULL
the	NULL
B-cell	NULL
lines	NULL
tested	NULL
,	NULL
indicating	NULL
that	NULL
sequences	NULL
outside	NULL
the	NULL
E-boxes	NULL
are	NULL
important	NULL
determinants	NULL
for	NULL
cell-type-directed	NULL
function	NULL
of	NULL
the	NULL
E-boxes	NULL
in	NULL
Aky	NULL
MLV	NULL
and	NULL
SL3-3	NULL
MLV	NULL
.	NULL

DISCUSSION	NULL
For	NULL
study	NULL
of	NULL
transcriptional	NULL
regulation	NULL
,	NULL
MLVs	NULL
represent	NULL
an	NULL
excellent	NULL
model	NULL
system	NULL
,	NULL
with	NULL
their	NULL
regulatory	NULL
sequences	NULL
localized	NULL
in	NULL
a	NULL
well-defined	NULL
DNA	NULL
segment	NULL
in	NULL
the	NULL
LTR	NULL
and	NULL
with	NULL
regulation	NULL
dependent	NULL
exclusively	NULL
on	NULL
cellular	NULL
transcription	NULL
factors	NULL
.	NULL

By	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
,	NULL
we	NULL
found	NULL
that	NULL
the	NULL
two	NULL
types	NULL
of	NULL
promoter-enhancer-localized	NULL
E-boxes	NULL
,	NULL
E.	NULL
,	NULL
,	NULL
and	NULL
Ea	NULL
,	NULL
g	NULL
,	NULL
in	NULL
Aky	NULL
MLV	NULL
and	NULL
SL3-3	NULL
MLV	NULL
bind	NULL
distinct	NULL
protein	NULL
complexes	NULL
.	NULL

Supershift	NULL
analysis	NULL
using	NULL
specific	NULL
antibodies	NULL
directed	NULL
against	NULL
ALF1	NULL
or	NULL
HEB	NULL
or	NULL
EZA	NULL
showed	NULL
that	NULL
the	NULL
E	NULL
,	NULL
,	NULL
,	NULL
E-boxes	NULL
bound	NULL
ALF1	NULL
or	NULL
HEB	NULL
and	NULL
E2A	NULL
proteins	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
lymphoid	NULL
cell	NULL
lines	NULL
,	NULL
whereas	NULL
the	NULL
E	NULL
,	NULL
,	NULL
E-box	NULL
complex	NULL
did	NULL
not	NULL
include	NULL
ALF1	NULL
or	NULL
HEB	NULL
or	NULL
EZA	NULL
.	NULL

The	NULL
E	NULL
,	NULL
,	NULL
,	NULL
E-box	NULL
complex	NULL
was	NULL
found	NULL
to	NULL
include	NULL
both	NULL
ALF1	NULL
or	NULL
HEB	NULL
and	NULL
E2ZA	NULL
,	NULL
suggesting	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
heterodimer	NULL
.	NULL

Previous	NULL
reports	NULL
have	NULL
described	NULL
such	NULL
a	NULL
heterodimeric	NULL
E-box	NULL
binding	NULL
complex	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
NIH	NULL
3T3	NULL
and	NULL
HeLa	NULL
cells	NULL
included	NULL
no	NULL
E-box-binding	NULL
capacity	NULL
of	NULL
ALF1	NULL
or	NULL
EZA	NULL
proteins	NULL
.	NULL

In	NULL
transfection	NULL
analysis	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
ALF1	NULL
,	NULL
HEB	NULL
or	NULL
E2A	NULL
homodimeric	NULL
protein	NULL
complexes	NULL
transactivated	NULL
transcription	NULL
from	NULL
the	NULL
Akv	NULL
MLV	NULL
enhancer	NULL
to	NULL
the	NULL
same	NULL
level	NULL
as	NULL
when	NULL
the	NULL
proteins	NULL
were	NULL
coexpressed	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
there	NULL
is	NULL
no	NULL
synergistic	NULL
effect	NULL
of	NULL
ALF1	NULL
or	NULL
HEB	NULL
and	NULL
E2A	NULL
proteins	NULL
.	NULL

However	NULL
,	NULL
a	NULL
putative	NULL
heterodimer-ization	NULL
may	NULL
result	NULL
in	NULL
stabilization	NULL
compared	NULL
with	NULL
the	NULL
relatively	NULL
labile	NULL
homodimer	NULL
complex	NULL
,	NULL
e.g	NULL
.	NULL

,	NULL
resulting	NULL
in	NULL
greater	NULL
resistance	NULL
to	NULL
dissociation	NULL
,	NULL
as	NULL
observed	NULL
for	NULL
EZ2A-TAL1	NULL
heterodimers	NULL
(	NULL
16	NULL
,	NULL
30	NULL
)	NULL
,	NULL
or	NULL
a	NULL
changed	NULL
DNA	NULL
specificity	NULL
,	NULL
which	NULL
we	NULL
were	NULL
not	NULL
able	NULL
to	NULL
observe	NULL
using	NULL
the	NULL
MLV	NULL
E-boxes	NULL
.	NULL

We	NULL
should	NULL
draw	NULL
attention	NULL
to	NULL
the	NULL
fact	NULL
that	NULL
homodimeric	NULL
ALF1/HEB	NULL
and	NULL
E2A	NULL
proteins	NULL
have	NULL
different	NULL
preferred	NULL
DNA-binding	NULL
sites	NULL
(	NULL
5	NULL
,	NULL
42	NULL
)	NULL
.	NULL

Some	NULL
of	NULL
the	NULL
E-box	NULL
complexes	NULL
detected	NULL
in	NULL
this	NULL
work	NULL
did	NULL
not	NULL
contain	NULL
ALF1	NULL
or	NULL
ALF2	NULL
or	NULL
E2A	NULL
proteins	NULL
.	NULL

Complexes	NULL
formed	NULL
on	NULL
E	NULL
,	NULL
,	NULL
,	NULL
and	NULL
without	NULL
class	NULL
A	NULL
bHLH	NULL
components	NULL
might	NULL
be	NULL
transcriptional	NULL
repressors	NULL
,	NULL
as	NULL
proposed	NULL
for	NULL
E-boxes	NULL
in	NULL
immunoglobulin	NULL
enhancers	NULL
,	NULL
in	NULL
which	NULL
the	NULL
transcriptional	NULL
repressor	NULL
ZEB	NULL
regulates	NULL
transcriptional	NULL
regulation	NULL
through	NULL
E-box	NULL
sequences	NULL
11	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
y	NULL
introduction	NULL
of	NULL
mutations	NULL
in	NULL
the	NULL
Akv	NULL
MLV	NULL
E-boxes	NULL
,	NULL
we	NULL
examined	NULL
their	NULL
putative	NULL
function	NULL
as	NULL
targets	NULL
for	NULL
activators	NULL
and	NULL
repressors	NULL
.	NULL

In	NULL
fibroblasts	NULL
and	NULL
HeLa	NULL
cells	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
E-boxes	NULL
only	NULL
moderately	NULL
affected	NULL
the	NULL
transcriptional	NULL
activity	NULL
.	NULL

This	NULL
is	NULL
in	NULL
accordance	NULL
with	NULL
the	NULL
absence	NULL
of	NULL
functional	NULL
class	NULL
A	NULL
bHLH	NULL
E-box	NULL
DNA-binding	NULL
activity	NULL
in	NULL
fibroblasts	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
Aky	NULL
MLV	NULL
reporter	NULL
constructs	NULL
with	NULL
mutations	NULL
in	NULL
the	NULL
two	NULL
E	NULL
,	NULL
,	NULL
,	NULL
E-boxes	NULL
(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
and	NULL
the	NULL
Ea	NULL
,	NULL
,	NULL
showed	NULL
that	NULL
the	NULL
expression	NULL
was	NULL
reduced	NULL
to	NULL
10	NULL
to	NULL
20	NULL
%	NULL
of	NULL
that	NULL
of	NULL
the	NULL
parental	NULL
Aky	NULL
MLV	NULL
reporter	NULL
,	NULL
suggesting	NULL
a	NULL
very	NULL
central	NULL
role	NULL
in	NULL
the	NULL
enhancer	NULL
function	NULL
of	NULL
E-box-binding	NULL
proteins	NULL
either	NULL
alone	NULL
or	NULL
in	NULL
a	NULL
larger	NULL
complex	NULL
with	NULL
other	NULL
proteins	NULL
involved	NULL
in	NULL
the	NULL
transcriptional	NULL
regulation	NULL
.	NULL

This	NULL
shows	NULL
that	NULL
the	NULL
E-boxes	NULL
in	NULL
the	NULL
enhancer	NULL
region	NULL
are	NULL
essential	NULL
for	NULL
proper	NULL
Aky	NULL
MLV	NULL
transcription	NULL
in	NULL
lymphoid	NULL
cell	NULL
lines	NULL
and	NULL
suggests	NULL
an	NULL
important	NULL
role	NULL
for	NULL
the	NULL
observed	NULL
E-box-binding	NULL
ALF1	NULL
or	NULL
HEB	NULL
and	NULL
EZA	NULL
proteins	NULL
in	NULL
Aky	NULL
MLV	NULL
transcriptional	NULL
regulation	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
and	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

In	NULL
T-cell	NULL
lines	NULL
,	NULL
mutation	NULL
of	NULL
each	NULL
of	NULL
the	NULL
E	NULL
,	NULL
,	NULL
,	NULL
E-boxes	NULL
and	NULL
E	NULL
,	NULL
,	NULL
reduced	NULL
the	NULL
transcriptional	NULL
activity	NULL
equally	NULL
,	NULL
and	NULL
the	NULL
double	NULL
mutation	NULL
decreased	NULL
the	NULL
activity	NULL
even	NULL
further	NULL
in	NULL
L691-6	NULL
cells	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
in	NULL
B-cell	NULL
lines	NULL
,	NULL
the	NULL
promoter-proximal	NULL
enhancer	NULL
E-box	NULL
,	NULL
E	NULL
,	NULL
,	NULL
_	NULL
(	NULL
B	NULL
)	NULL
,	NULL
was	NULL
most	NULL
important	NULL
for	NULL
Akv	NULL
expression	NULL
,	NULL
indicating	NULL
a	NULL
different	NULL
composition	NULL
of	NULL
the	NULL
E-box	NULL
binding	NULL
complex	NULL
in	NULL
T-	NULL
and	NULL
B-cell	NULL
lines	NULL
.	NULL

5900	NULL
NIELSEN	NULL
ET	NULL
AL	NULL
.	NULL

Ectopic	NULL
expression	NULL
of	NULL
ALF1	NULL
in	NULL
NIH	NULL
3T3	NULL
cells	NULL
showed	NULL
that	NULL
ALF	NULL
]	NULL
transactivated	NULL
equivalently	NULL
through	NULL
the	NULL
two	NULL
enhancer	NULL
E	NULL
,	NULL
,	NULL
,	NULL
E-boxes	NULL
,	NULL
similar	NULL
to	NULL
the	NULL
situation	NULL
of	NULL
E-box	NULL
regulation	NULL
in	NULL
T-cell	NULL
lines	NULL
,	NULL
whereas	NULL
overexpression	NULL
of	NULL
the	NULL
E2A	NULL
protein	NULL
,	NULL
E2-5	NULL
,	NULL
transactivated	NULL
with	NULL
preference	NULL
through	NULL
the	NULL
more	NULL
promoter	NULL
proximal	NULL
of	NULL
the	NULL
enhancer	NULL
E-boxes	NULL
,	NULL
E	NULL
,	NULL
,	NULL
\	NULL
(	NULL
B	NULL
)	NULL
,	NULL
equivalent	NULL
to	NULL
the	NULL
E-box	NULL
requirement	NULL
in	NULL
B-cell	NULL
lines	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

The	NULL
different	NULL
E-box	NULL
requirements	NULL
in	NULL
E2A	NULL
protein	NULL
E2-5-	NULL
and	NULL
ALF1-mediated	NULL
transcriptional	NULL
activation	NULL
suggest	NULL
that	NULL
these	NULL
two	NULL
very	NULL
homologous	NULL
proteins	NULL
contact	NULL
the	NULL
transcriptional	NULL
machinery	NULL
formed	NULL
on	NULL
the	NULL
MLV	NULL
promoter-enhancer	NULL
differently	NULL
.	NULL

The	NULL
only	NULL
known	NULL
function	NULL
of	NULL
the	NULL
family	NULL
of	NULL
Id	NULL
proteins	NULL
is	NULL
to	NULL
repress	NULL
the	NULL
function	NULL
of	NULL
class	NULL
A	NULL
bHLH	NULL
proteins	NULL
.	NULL

We	NULL
have	NULL
measured	NULL
the	NULL
effect	NULL
of	NULL
Id	NULL
overexpression	NULL
to	NULL
see	NULL
if	NULL
repression	NULL
may	NULL
be	NULL
detected	NULL
in	NULL
MLV	NULL
transcription	NULL
.	NULL

Id1	NULL
was	NULL
previously	NULL
described	NULL
to	NULL
be	NULL
a	NULL
repressor	NULL
of	NULL
DNA	NULL
binding	NULL
and	NULL
of	NULL
transcriptional	NULL
activation	NULL
by	NULL
EZ2A	NULL
proteins	NULL
(	NULL
4	NULL
,	NULL
19	NULL
,	NULL
43	NULL
)	NULL
.	NULL

We	NULL
found	NULL
that	NULL
Id1	NULL
repressed	NULL
ALF1	NULL
DNA	NULL
binding	NULL
in	NULL
vitro	NULL
and	NULL
that	NULL
ectopic	NULL
expression	NULL
of	NULL
Id1	NULL
resulted	NULL
in	NULL
a	NULL
decrease	NULL
in	NULL
ALF1l-mediated	NULL
transactivation	NULL
of	NULL
Aky	NULL
MLV	NULL
and	NULL
SL3-3	NULL
MLV	NULL
transcription	NULL
in	NULL
vivo	NULL
.	NULL

Thus	NULL
,	NULL
Id1	NULL
has	NULL
the	NULL
characteristics	NULL
expected	NULL
for	NULL
a	NULL
repressor	NULL
of	NULL
ALF1l-mediated	NULL
transcriptional	NULL
activation	NULL
.	NULL

According	NULL
to	NULL
this	NULL
,	NULL
we	NULL
found	NULL
that	NULL
in	NULL
a	NULL
T-cell	NULL
line	NULL
ectopic	NULL
Id1	NULL
repressed	NULL
transcription	NULL
of	NULL
Aky	NULL
MLV	NULL
and	NULL
SL3-3	NULL
MLV	NULL
.	NULL

Repression	NULL
by	NULL
Id1	NULL
required	NULL
intact	NULL
E..	NULL
,	NULL
motifs	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

This	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
our	NULL
observations	NULL
showing	NULL
that	NULL
the	NULL
E	NULL
,	NULL
,	NULL
,	NULL
motifs	NULL
,	NULL
and	NULL
not	NULL
the	NULL
Ex	NULL
,	NULL
motif	NULL
,	NULL
bind	NULL
class	NULL
A	NULL
bHLH	NULL
protein-including	NULL
protein	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

We	NULL
found	NULL
different	NULL
sensitivities	NULL
to	NULL
Id	NULL
repression	NULL
of	NULL
Akv	NULL
and	NULL
SL3-3	NULL
MLV	NULL
expression	NULL
in	NULL
B-cell	NULL
lines	NULL
.	NULL

This	NULL
may	NULL
reflect	NULL
various	NULL
concentrations	NULL
of	NULL
endogenous	NULL
bHLH	NULL
proteins	NULL
in	NULL
the	NULL
different	NULL
cell	NULL
types	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
R.	NULL
Baer	NULL
for	NULL
donation	NULL
of	NULL
the	NULL
pCMV4-Id1	NULL
plasmid	NULL
,	NULL
R.	NULL
Rivera	NULL
for	NULL
the	NULL
E12	NULL
plasmid	NULL
,	NULL
T.	NULL
Kadesch	NULL
for	NULL
the	NULL
E2-5	NULL
plasmid	NULL
,	NULL
and	NULL
D.	NULL
Littman	NULL
for	NULL
the	NULL
«	NULL
HEB	NULL
antiserum	NULL
.	NULL

We	NULL
thank	NULL
Claus	NULL
Bus	NULL
for	NULL
technical	NULL
assistance	NULL
.	NULL

This	NULL
project	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
Karen	NULL
Elise	NULL
Jensen	NULL
Foundation	NULL
,	NULL
the	NULL
Danish	NULL
Biotechnology	NULL
Program	NULL
,	NULL
the	NULL
Danish	NULL
Natural	NULL
Science	NULL
Research	NULL
Council	NULL
,	NULL
the	NULL
Novo	NULL
Nordisk	NULL
Foundation	NULL
,	NULL
and	NULL
the	NULL
Danish	NULL
Cancer	NULL
Society	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Andrews	NULL
,	NULL
N.	NULL
C.	NULL
,	NULL
and	NULL
D.	NULL
V.	NULL
Faller	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
rapid	NULL
micropreparation	NULL
technique	NULL
for	NULL
extraction	NULL
of	NULL
DNA-binding	NULL
proteins	NULL
from	NULL
limiting	NULL
numbers	NULL
of	NULL
mammalian	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

19:2499	NULL
.	NULL

2	NULL
.	NULL

Bain	NULL
,	NULL
G.	NULL
,	NULL
E.	NULL
R.	NULL
Maandag	NULL
,	NULL
D.	NULL
J.	NULL
Izon	NULL
,	NULL
D.	NULL
Amsen	NULL
,	NULL
A.	NULL
M.	NULL
Kruisbeek	NULL
,	NULL
B.	NULL
C.	NULL
Weintraub	NULL
,	NULL
I.	NULL
Krop	NULL
,	NULL
M.	NULL
S.	NULL
Schlissel	NULL
,	NULL
A.	NULL
J.	NULL
Feeney	NULL
,	NULL
M.	NULL
van	NULL
Roon	NULL
,	NULL
M.	NULL
van	NULL
der	NULL
Valk	NULL
,	NULL
P.	NULL
J.	NULL
T.	NULL
Riele	NULL
,	NULL
A.	NULL
Berns	NULL
,	NULL
and	NULL
C.	NULL
Murre	NULL
.	NULL

1994	NULL
.	NULL

E2A	NULL
proteins	NULL
are	NULL
required	NULL
for	NULL
proper	NULL
B	NULL
cell	NULL
development	NULL
and	NULL
initiation	NULL
of	NULL
immunoglobulin	NULL
gene	NULL
rear-rangements	NULL
.	NULL

Cell	NULL
79:885-892	NULL
.	NULL

3	NULL
.	NULL

Benezra	NULL
,	NULL
R.	NULL
1994	NULL
.	NULL

An	NULL
intermolecular	NULL
disulfide	NULL
bond	NULL
stabilizes	NULL
E2A	NULL
homodimers	NULL
and	NULL
is	NULL
required	NULL
for	NULL
DNA	NULL
binding	NULL
at	NULL
physiological	NULL
temperatures	NULL
.	NULL

Cell	NULL
79:1057-1067	NULL
.	NULL

4	NULL
.	NULL

Benezra	NULL
,	NULL
R.	NULL
,	NULL
R.	NULL
L.	NULL
Davis	NULL
,	NULL
D.	NULL
Lockshon	NULL
,	NULL
D.	NULL
L.	NULL
Turner	NULL
,	NULL
and	NULL
H.	NULL
Weintraub	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
protein	NULL
Id	NULL
:	NULL
a	NULL
negative	NULL
regulator	NULL
of	NULL
helix-loop-helix	NULL
DNA	NULL
binding	NULL
proteins	NULL
.	NULL

Cell	NULL
61:49-59	NULL
.	NULL

5	NULL
.	NULL

Bonven	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
A.	NULL
L.	NULL
Nielsen	NULL
,	NULL
P.	NULL
L.	NULL
Norby	NULL
,	NULL
F.	NULL
S.	NULL
Pedersen	NULL
,	NULL
and	NULL
P.	NULL
Jorgensen	NULL
.	NULL

1995	NULL
.	NULL

E-box	NULL
variants	NULL
direct	NULL
formation	NULL
of	NULL
distinct	NULL
complexes	NULL
with	NULL
the	NULL
basic	NULL
helix-loop-helix	NULL
protein	NULL
ALF1	NULL
.	NULL

J.	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

249:564-575	NULL
.	NULL

6	NULL
.	NULL

Celander	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
W.	NULL
A.	NULL
Haseltine	NULL
.	NULL

1984	NULL
.	NULL

Tissue-specific	NULL
transcription	NULL
preference	NULL
as	NULL
a	NULL
determinant	NULL
of	NULL
cell	NULL
tropism	NULL
and	NULL
leukaemogenic	NULL
potential	NULL
of	NULL
murine	NULL
retroviruses	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
312:159-162	NULL
.	NULL

7	NULL
.	NULL

Chatis	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
C.	NULL
A.	NULL
Holland	NULL
,	NULL
J.	NULL
E.	NULL
Silver	NULL
,	NULL
T.	NULL
N.	NULL
Frederickson	NULL
,	NULL
N.	NULL
Hopkins	NULL
,	NULL
and	NULL
J.	NULL
W.	NULL
Hartley	NULL
.	NULL

1984	NULL
.	NULL

A	NULL
3	NULL
'	NULL
end	NULL
fragment	NULL
encompassing	NULL
the	NULL
transcriptional	NULL
enhancers	NULL
of	NULL
nondefective	NULL
Friend	NULL
virus	NULL
confers	NULL
erythroleukemogenicity	NULL
on	NULL
Moloney	NULL
leukemia	NULL
virus	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

52:248-254	NULL
.	NULL

8	NULL
.	NULL

Christy	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
L.	NULL
K.	NULL
Sanders	NULL
,	NULL
L.	NULL
F.	NULL
Lau	NULL
,	NULL
N.	NULL
G.	NULL
Copeland	NULL
,	NULL
N.	NULL
A.	NULL
Jenkins	NULL
,	NULL
and	NULL
D.	NULL
Nathans	NULL
.	NULL

1991	NULL
.	NULL

An	NULL
Id-related	NULL
helix-loop-helix	NULL
protein	NULL
encoded	NULL
by	NULL
a	NULL
growth	NULL
factor-inducible	NULL
gene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:1815-1819	NULL
.	NULL

9	NULL
.	NULL

Corneliussen	NULL
,	NULL
B.	NULL
,	NULL
A.	NULL
Thornell	NULL
,	NULL
B.	NULL
Hallberg	NULL
,	NULL
and	NULL
T.	NULL
Grundstrom	NULL
.	NULL

1991	NULL
.	NULL

Helix-loop-helix	NULL
transcriptional	NULL
activators	NULL
bind	NULL
to	NULL
a	NULL
sequence	NULL
in	NULL
glucocorticoid	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

J.	NULL
ViRoL	NULL
.	NULL

response	NULL
elements	NULL
of	NULL
retrovirus	NULL
enhancers	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:6084-6093	NULL
.	NULL

Doyle	NULL
,	NULL
K.	NULL
,	NULL
Y.	NULL
Zhang	NULL
,	NULL
R.	NULL
Baer	NULL
,	NULL
and	NULL
M.	NULL
Bina	NULL
.	NULL

1994	NULL
.	NULL

Distinguishable	NULL
patterns	NULL
of	NULL
protein-DNA	NULL
interactions	NULL
involving	NULL
complexes	NULL
of	NULL
basic	NULL
helix-loop-helix	NULL
proteins	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:12099-12105	NULL
.	NULL

Genetta	NULL
,	NULL
T.	NULL
,	NULL
D.	NULL
Ruezinsky	NULL
,	NULL
and	NULL
T.	NULL
Kadesch	NULL
.	NULL

1994	NULL
.	NULL

Displacement	NULL
of	NULL
an	NULL
E-box-binding	NULL
repressor	NULL
by	NULL
basic	NULL
helix-loop-helix	NULL
proteins	NULL
:	NULL
implications	NULL
for	NULL
B-cell	NULL
specificity	NULL
of	NULL
the	NULL
immunoglobulin	NULL
heavy-chain	NULL
enhancer	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:6153-6163	NULL
.	NULL

Hallberg	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
T.	NULL
Grundstrom	NULL
.	NULL

1988	NULL
.	NULL

Tissue	NULL
specific	NULL
sequence	NULL
motifs	NULL
in	NULL
the	NULL
enhancer	NULL
of	NULL
the	NULL
leukaemogenic	NULL
mouse	NULL
retrovirus	NULL
SL3-3	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

16:5927-5944	NULL
.	NULL

Henthorn	NULL
,	NULL
P.	NULL
,	NULL
M.	NULL
Kiledjian	NULL
,	NULL
and	NULL
T.	NULL
Kadesch	NULL
.	NULL

1990	NULL
.	NULL

Two	NULL
distinct	NULL
transcription	NULL
factors	NULL
that	NULL
bind	NULL
the	NULL
immunoglobulin	NULL
enhancer	NULL
microE5/kappaF2	NULL
motif	NULL
.	NULL

Science	NULL
247:467-470	NULL
.	NULL

Hsu	NULL
,	NULL
H.	NULL
,	NULL
L.	NULL
Huang	NULL
,	NULL
J.	NULL
T.	NULL
Tsan	NULL
,	NULL
W.	NULL
Funk	NULL
,	NULL
W.	NULL
E.	NULL
Wright	NULL
,	NULL
J.	NULL
Hu	NULL
,	NULL
R.	NULL
E.	NULL
Kingston	NULL
,	NULL
and	NULL
R.	NULL
Baer	NULL
.	NULL

1994	NULL
.	NULL

Preferred	NULL
sequences	NULL
for	NULL
DNA	NULL
recognition	NULL
by	NULL
the	NULL
TAL1	NULL
helix-loop-helix	NULL
proteins	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:1256-1265	NULL
.	NULL

Hsu	NULL
,	NULL
H.	NULL
L.	NULL
,	NULL
J.	NULL
T.	NULL
Cheng	NULL
,	NULL
Q.	NULL
Chen	NULL
,	NULL
and	NULL
R.	NULL
Baer	NULL
,	NULL
1991	NULL
.	NULL

Enhancer-binding	NULL
activity	NULL
of	NULL
the	NULL
tal-1	NULL
oncoprotein	NULL
in	NULL
association	NULL
with	NULL
the	NULL
E47/E12	NULL
helix-loop-helix	NULL
proteins	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:3037-3042	NULL
.	NULL

Hsu	NULL
,	NULL
H.	NULL
L.	NULL
,	NULL
I	NULL
Wadman	NULL
,	NULL
J.	NULL
T.	NULL
Tsan	NULL
,	NULL
and	NULL
R.	NULL
Baer	NULL
.	NULL

1994	NULL
.	NULL

Positive	NULL
and	NULL
negative	NULL
transcriptional	NULL
control	NULL
by	NULL
the	NULL
TAL1	NULL
helix-loop-helix	NULL
protein	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:3181-3185	NULL
.	NULL

Hu	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
E.	NULL
N.	NULL
Olson	NULL
,	NULL
and	NULL
R.	NULL
E.	NULL
Kingston	NULL
.	NULL

1992	NULL
.	NULL

HEB	NULL
,	NULL
a	NULL
helix-loop-helix	NULL
protein	NULL
related	NULL
to	NULL
E2A	NULL
and	NULL
ITF2	NULL
that	NULL
can	NULL
modulate	NULL
the	NULL
DNA-binding	NULL
ability	NULL
of	NULL
myogenic	NULL
regulatory	NULL
factors	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:1031-1042	NULL
.	NULL

Jacobs	NULL
,	NULL
Y.	NULL
,	NULL
C.	NULL
Vierra	NULL
,	NULL
and	NULL
C.	NULL
Nelson	NULL
.	NULL

1993	NULL
.	NULL

E2A	NULL
expression	NULL
,	NULL
nuclear	NULL
local-ization	NULL
,	NULL
and	NULL
in	NULL
vivo	NULL
formation	NULL
of	NULL
DNA-	NULL
and	NULL
non-DNA-binding	NULL
species	NULL
during	NULL
B-cell	NULL
development	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:7321-7333	NULL
.	NULL

Jen	NULL
,	NULL
Y.	NULL
,	NULL
H.	NULL
Weintraub	NULL
,	NULL
and	NULL
R.	NULL
Benezra	NULL
.	NULL

1992	NULL
.	NULL

Overexpression	NULL
of	NULL
Id	NULL
protein	NULL
inhibits	NULL
the	NULL
muscle	NULL
differentiation	NULL
program	NULL
:	NULL
in	NULL
vivo	NULL
association	NULL
of	NULL
Id	NULL
with	NULL
E2A	NULL
proteins	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:1466-1479	NULL
.	NULL

Klein	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
D.	NULL
M.	NULL
Simmons	NULL
,	NULL
L.	NULL
W.	NULL
Swanson	NULL
,	NULL
and	NULL
M.	NULL
G.	NULL
Rosenfeld	NULL
.	NULL

1993	NULL
.	NULL

Tissue-specific	NULL
RNA	NULL
splicing	NULL
generates	NULL
an	NULL
ankyrin-like	NULL
domain	NULL
that	NULL
affects	NULL
the	NULL
dimerization	NULL
and	NULL
DNA-binding	NULL
properties	NULL
of	NULL
a	NULL
bHLH	NULL
protein	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:55-71	NULL
.	NULL

Lawrenz-Smith	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
and	NULL
C.	NULL
Y.	NULL
Thomas	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
E47	NULL
transcription	NULL
factor	NULL
binds	NULL
to	NULL
the	NULL
enhancer	NULL
sequences	NULL
of	NULL
recombinant	NULL
murine	NULL
leukemia	NULL
viruses	NULL
and	NULL
influences	NULL
enhancer	NULL
function	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:4142-4148	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
,	NULL
J.	NULL
W.	NULL
Pierce	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1987	NULL
.	NULL

Protcin-binding	NULL
sites	NULL
in	NULL
Ig	NULL
gene	NULL
enhancers	NULL
determine	NULL
transcriptional	NULL
activity	NULL
and	NULL
inducibility	NULL
.	NULL

Science	NULL
236:1573-1577	NULL
.	NULL

Lenz	NULL
,	NULL
J.	NULL
,	NULL
D.	NULL
Celander	NULL
,	NULL
R.	NULL
L.	NULL
Crowther	NULL
,	NULL
R.	NULL
Patarca	NULL
,	NULL
D.	NULL
W.	NULL
Perkins	NULL
,	NULL
and	NULL
W.	NULL
A.	NULL
Haseltine	NULL
.	NULL

1984	NULL
.	NULL

Determination	NULL
of	NULL
the	NULL
leukaemogenicity	NULL
of	NULL
a	NULL
murine	NULL
retrovirus	NULL
by	NULL
sequences	NULL
within	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
308	NULL
:	NULL
467-470.	NULL
.	NULL

Lovmand	NULL
,	NULL
J	NULL
.	NULL

Personal	NULL
communication	NULL
.	NULL

.	NULL

Lovmand	NULL
,	NULL
S.	NULL
,	NULL
N.	NULL
O.	NULL
Kjeldgaard	NULL
,	NULL
P.	NULL
Jorgensen	NULL
,	NULL
and	NULL
F.	NULL
S.	NULL
Pedersen	NULL
.	NULL

1990	NULL
.	NULL

Enhancer	NULL
functions	NULL
in	NULL
U3	NULL
of	NULL
Aky	NULL
virus	NULL
:	NULL
a	NULL
role	NULL
for	NULL
cooperativity	NULL
of	NULL
a	NULL
tandem	NULL
repeat	NULL
unit	NULL
and	NULL
its	NULL
flanking	NULL
DNA	NULL
sequences	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:3185-3191	NULL
.	NULL

Murre	NULL
,	NULL
C.	NULL
,	NULL
G.	NULL
Bain	NULL
,	NULL
M.	NULL
A.	NULL
van	NULL
Dijk	NULL
,	NULL
I	NULL
Engel	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Furnari	NULL
,	NULL
M.	NULL
E.	NULL
Massari	NULL
,	NULL
J.	NULL
R.	NULL
Matthews	NULL
,	NULL
M.	NULL
W.	NULL
Quong	NULL
,	NULL
R.	NULL
R.	NULL
Rivera	NULL
,	NULL
and	NULL
M.	NULL
H.	NULL
Stuiver	NULL
.	NULL

1994	NULL
.	NULL

Structure	NULL
and	NULL
function	NULL
of	NULL
helix-loop-helix	NULL
proteins	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1218:129-135	NULL
.	NULL

Murre	NULL
,	NULL
C.	NULL
,	NULL
P.	NULL
S.	NULL
McCaw	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
new	NULL
DNA	NULL
binding	NULL
and	NULL
dimerization	NULL
motif	NULL
in	NULL
immunoglobulin	NULL
enhancer	NULL
binding	NULL
,	NULL
daughterless	NULL
,	NULL
MyoD	NULL
,	NULL
and	NULL
mye	NULL
proteins	NULL
.	NULL

Cell	NULL
56:777-783	NULL
.	NULL

Murre	NULL
,	NULL
C.	NULL
,	NULL
P.	NULL
S.	NULL
McCaw	NULL
,	NULL
H.	NULL
Vaessin	NULL
,	NULL
M.	NULL
Caudy	NULL
,	NULL
L.	NULL
Y.	NULL
Jan	NULL
,	NULL
Y.	NULL
N.	NULL
Jan	NULL
,	NULL
C.	NULL
V.	NULL
Cabrera	NULL
,	NULL
J.	NULL
N.	NULL
Buskin	NULL
,	NULL
S.	NULL
D.	NULL
Hauschka	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
Lassar	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
.	NULL

Interactions	NULL
between	NULL
heterologous	NULL
helix-loop-helix	NULL
proteins	NULL
generate	NULL
complexes	NULL
that	NULL
bind	NULL
specifically	NULL
to	NULL
a	NULL
common	NULL
DNA	NULL
sequence	NULL
.	NULL

Cell	NULL
58:537-544	NULL
.	NULL

Murre	NULL
,	NULL
C.	NULL
,	NULL
A.	NULL
Voronova	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1991	NULL
.	NULL

B-cell-	NULL
and	NULL
myocyte-specific	NULL
E2-box-binding	NULL
factors	NULL
contain	NULL
E12/F47-like	NULL
subunits	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
:	NULL
1156-1160	NULL
.	NULL

Nielsen	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
P.	NULL
L.	NULL
Norby	NULL
,	NULL
F.	NULL
S.	NULL
Pedersen	NULL
,	NULL
and	NULL
P.	NULL
Jorgensen	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

Nielsen	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
N.	NULL
Pallisgaard	NULL
,	NULL
F.	NULL
S.	NULL
Pedersen	NULL
,	NULL
and	NULL
P.	NULL
Jorgensen	NULL
.	NULL

1992	NULL
.	NULL

Murine	NULL
helix-loop-helix	NULL
transcriptional	NULL
activator	NULL
proteins	NULL
binding	NULL
to	NULL
the	NULL
E-box	NULL
motif	NULL
of	NULL
the	NULL
Aky	NULL
murine	NULL
leukemia	NULL
virus	NULL
enhancer	NULL
identified	NULL
by	NULL
cDNA	NULL
cloning	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:3449-3459	NULL
.	NULL

Nielsen	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
N.	NULL
Pallisgaard	NULL
,	NULL
F.	NULL
S.	NULL
Pedersen	NULL
,	NULL
and	NULL
P.	NULL
Jorgensen	NULL
.	NULL

1994	NULL
.	NULL

Basic	NULL
helix-loop-helix	NULL
proteins	NULL
in	NULL
murine	NULL
type	NULL
C	NULL
retrovirus	NULL
transcriptional	NULL
regulation	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:5638-5647	NULL
.	NULL

Pallisgaard	NULL
,	NULL
N.	NULL
,	NULL
F.	NULL
S.	NULL
Pedersen	NULL
,	NULL
S.	NULL
Birkelund	NULL
,	NULL
and	NULL
P.	NULL
Jorgensen	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
common	NULL
multiple	NULL
cloning	NULL
site	NULL
in	NULL
a	NULL
set	NULL
of	NULL
vectors	NULL
for	NULL
expression	NULL
of	NULL
eukaryotic	NULL
genes	NULL
in	NULL
mammalian	NULL
,	NULL
insect	NULL
and	NULL
in	NULL
bacterial	NULL
cells	NULL
.	NULL

Gene	NULL
138:115-118	NULL
.	NULL

Paludan	NULL
,	NULL
K.	NULL
,	NULL
H.	NULL
Y.	NULL
Dai	NULL
,	NULL
M.	NULL
Duch	NULL
,	NULL
P.	NULL
Jorgensen	NULL
,	NULL
N.	NULL
O.	NULL
Kjeldgaard	NULL
,	NULL
and	NULL
F.	NULL
S.	NULL
Pedersen	NULL
.	NULL

1989	NULL
.	NULL

Different	NULL
relative	NULL
expression	NULL
from	NULL
two	NULL
murine	NULL
leukemia	NULL
virus	NULL
long	NULL
terminal	NULL
repeats	NULL
in	NULL
unintegrated	NULL
transfected	NULL
DNA	NULL
and	NULL
in	NULL
integrated	NULL
retroviral	NULL
vector	NULL
proviruses	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:5201-5207	NULL
.	NULL

Pedersen	NULL
,	NULL
F.	NULL
S.	NULL
,	NULL
M.	NULL
Etzerodt	NULL
,	NULL
S.	NULL
Lovmand	NULL
,	NULL
H.	NULL
Y.	NULL
Dai	NULL
,	NULL
A.	NULL
J.	NULL
Bzekgaard	NULL
,	NULL
J.	NULL
Sprensen	NULL
,	NULL
P.	NULL
Jorgensen	NULL
,	NULL
N.	NULL
O.	NULL
Kjeldgaard	NULL
,	NULL
J.	NULL
Schmidt	NULL
,	NULL
C.	NULL
Leib-Misch	NULL
,	NULL
A.	NULL
VoL	NULL
.	NULL

70	NULL
,	NULL
1996	NULL
36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

Luz	NULL
,	NULL
and	NULL
V.	NULL
Erfle	NULL
.	NULL

1987	NULL
.	NULL

Transcriptional	NULL
control	NULL
and	NULL
oncogenicity	NULL
of	NULL
murine	NULL
leukemia	NULL
viruses	NULL
,	NULL
p.	NULL
17-35	NULL
.	NULL

In	NULL
N.	NULL
O.	NULL
Kjeldgaard	NULL
,	NULL
and	NULL
J.	NULL
Forchhammer	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Viral	NULL
carcinogenesis	NULL
,	NULL
Alfred	NULL
Benzon	NULL
Symposium	NULL
24	NULL
.	NULL

Munksgaard	NULL
,	NULL
Copenha-gen.	NULL
Pongubala	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
M.	NULL
L.	NULL
Atchison	NULL
.	NULL

1991	NULL
.	NULL

Functional	NULL
characterization	NULL
of	NULL
the	NULL
developmentally	NULL
controlled	NULL
immunoglobulin	NULL
kappa	NULL
3	NULL
'	NULL
enhancer	NULL
:	NULL
regulation	NULL
by	NULL
Id	NULL
,	NULL
a	NULL
repressor	NULL
of	NULL
helix-loop-helix	NULL
transcription	NULL
factors	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:1040-1047	NULL
.	NULL

Riechmann	NULL
,	NULL
V.	NULL
,	NULL
I.	NULL
van	NULL
Cruchten	NULL
,	NULL
and	NULL
F.	NULL
Sablitzky	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
expression	NULL
pattern	NULL
of	NULL
Id4	NULL
,	NULL
a	NULL
novel	NULL
dominant	NULL
negative	NULL
helix-loop-helix	NULL
protein	NULL
,	NULL
is	NULL
distinct	NULL
from	NULL
Id1	NULL
,	NULL
Id2	NULL
and	NULL
Id3	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

22:749-755	NULL
.	NULL

Sawada	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
D.	NULL
R.	NULL
Littman	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
heterodimer	NULL
of	NULL
HEB	NULL
and	NULL
an	NULL
E12-related	NULL
protein	NULL
interacts	NULL
with	NULL
the	NULL
CD4	NULL
enhancer	NULL
and	NULL
regulates	NULL
its	NULL
activity	NULL
in	NULL
T-cell	NULL
lines	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:5620-5628	NULL
.	NULL

Sekido	NULL
,	NULL
R.	NULL
,	NULL
K.	NULL
Murai	NULL
,	NULL
J.	NULL
Funahashi	NULL
,	NULL
Y.	NULL
Kamachi	NULL
,	NULL
A.	NULL
Fujisawa	NULL
Sehara	NULL
,	NULL
Y.	NULL
Nabeshima	NULL
,	NULL
and	NULL
H.	NULL
Kondoh	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
delta-crystallin	NULL
enhancer-binding	NULL
protein	NULL
delta	NULL
EF1	NULL
is	NULL
a	NULL
repressor	NULL
of	NULL
E2-box-mediated	NULL
gene	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:5692-5700	NULL
.	NULL

Speck	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
B.	NULL
Renjifo	NULL
,	NULL
and	NULL
N.	NULL
Hopkins	NULL
.	NULL

1990	NULL
.	NULL

Point	NULL
mutations	NULL
in	NULL
the	NULL
Moloney	NULL
murine	NULL
leukemia	NULL
virus	NULL
enhancer	NULL
identify	NULL
a	NULL
lymphoid-specific	NULL
viral	NULL
core	NULL
motif	NULL
and	NULL
1,3-phorbol	NULL
myristate	NULL
acetate-inducible	NULL
element	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:543-550	NULL
.	NULL

Sun	NULL
,	NULL
X.	NULL
H.	NULL
1994	NULL
.	NULL

Constitutive	NULL
expression	NULL
of	NULL
the	NULL
Id1	NULL
gene	NULL
impairs	NULL
mouse	NULL
B	NULL
bHLH	NULL
PROTEINS	NULL
REGULATE	NULL
MLV	NULL
TRANSCRIPTION	NULL
42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

5901	NULL
cell	NULL
development	NULL
.	NULL

Cell	NULL
79:893-900	NULL
.	NULL

Sun	NULL
,	NULL
X.	NULL
H.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1991	NULL
.	NULL

An	NULL
inhibitory	NULL
domain	NULL
of	NULL
E12	NULL
transcription	NULL
factor	NULL
prevents	NULL
DNA	NULL
binding	NULL
in	NULL
E12	NULL
homodimers	NULL
but	NULL
not	NULL
in	NULL
E12	NULL
het-erodimers	NULL
.	NULL

Cell	NULL
64:459-470	NULL
.	NULL

Sun	NULL
,	NULL
X.	NULL
H.	NULL
,	NULL
N.	NULL
G.	NULL
Copeland	NULL
,	NULL
N.	NULL
A.	NULL
Jenkins	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1991	NULL
.	NULL

Id	NULL
proteins	NULL
Id1	NULL
and	NULL
Id2	NULL
selectively	NULL
inhibit	NULL
DNA	NULL
binding	NULL
by	NULL
one	NULL
class	NULL
of	NULL
helix-loop-helix	NULL
proteins	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:5603-5611	NULL
.	NULL

Weiss	NULL
,	NULL
R.	NULL
,	NULL
N.	NULL
Teich	NULL
,	NULL
H.	NULL
E.	NULL
Varmus	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Coffin	NULL
.	NULL

1985	NULL
.	NULL

RNA	NULL
tumor	NULL
viruses	NULL
.	NULL

Molecular	NULL
biology	NULL
of	NULL
the	NULL
tumor	NULL
viruses	NULL
,	NULL
2nd	NULL
ed	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
N.Y.	NULL
Wilson	NULL
,	NULL
R.	NULL
B.	NULL
,	NULL
M.	NULL
Kiledjian	NULL
,	NULL
C.	NULL
P.	NULL
Shen	NULL
,	NULL
R.	NULL
Benezra	NULL
,	NULL
P.	NULL
Zwollo	NULL
,	NULL
S.	NULL
M.	NULL
Dymecki	NULL
,	NULL
S.	NULL
V.	NULL
Desiderio	NULL
,	NULL
and	NULL
T.	NULL
Kadesch	NULL
.	NULL

1991	NULL
.	NULL

Repression	NULL
of	NULL
immunoglobulin	NULL
enhancers	NULL
by	NULL
the	NULL
helix-loop-helix	NULL
protein	NULL
Id	NULL
:	NULL
implications	NULL
for	NULL
B-lymphoid-cell	NULL
development	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:6185-6191	NULL
.	NULL

Zhang	NULL
,	NULL
Y.	NULL
,	NULL
J.	NULL
Babin	NULL
,	NULL
A.	NULL
L.	NULL
Feldhaus	NULL
,	NULL
H.	NULL
Singh	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
,	NULL
and	NULL
M.	NULL
Bina	NULL
.	NULL

1991	NULL
.	NULL

HTF4	NULL
:	NULL
a	NULL
new	NULL
human	NULL
helix-loop-helix	NULL
protein	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

19:4555	NULL
.	NULL

Zhang	NULL
,	NULL
Y.	NULL
,	NULL
K.	NULL
Doyle	NULL
,	NULL
and	NULL
M.	NULL
Bina	NULL
.	NULL

1992	NULL
.	NULL

Interactions	NULL
of	NULL
HTF4	NULL
with	NULL
E-box	NULL
motifs	NULL
in	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:5631-5634	NULL
.	NULL

Zhuang	NULL
,	NULL
Y.	NULL
,	NULL
P.	NULL
Soriano	NULL
,	NULL
and	NULL
H.	NULL
Weintraub	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
helix-loop-helix	NULL
gene	NULL
E2A	NULL
is	NULL
required	NULL
for	NULL
B	NULL
cell	NULL
formation	NULL
.	NULL

Cell	NULL
79:875-884	NULL
.	NULL

